Data Dictionary
You Searched For: SECF
SECF is a Confidential Series
| MDRM Item | Start Date | End Date | Item Name | Reporting Forms |
|---|---|---|---|---|
| SECF0045 | 2000-03-31 | 9999-12-31 | CODE INDICATOR WHETHER THE FR Y-20 REPORT IS CONSOLIDATED OR NOT | SEC 1695/1696 |
| SECF0425 | 2000-03-31 | 9999-12-31 | SECURITIES PURCHASED UNDER AGREEMENTS TO RESELL | SEC 1695/1696 |
| SECF2130 | 2000-03-31 | 9999-12-31 | INVESTMENTS AND UNCONSOLIDATED SUBSIDIARIES AND ASSOCIATED COMPANIES | SEC 1695/1696 |
| SECF2145 | 2000-03-31 | 9999-12-31 | PREMISES AND FIXED ASSETS (INCLUDING RIGHT OF USE ASSETS) | SEC 1695/1696 |
| SECF2160 | 2000-03-31 | 9999-12-31 | OTHER ASSETS | SEC 1695/1696 |
| SECF2170 | 2000-03-31 | 9999-12-31 | TOTAL ASSETS | SEC 1695/1696 |
| SECF2552 | 2000-03-31 | 9999-12-31 | TOTAL CREDIT BALANCES | SEC 1695/1696 |
| SECF2948 | 2000-03-31 | 9999-12-31 | TOTAL LIABILITIES AND MINORITY INTEREST | SEC 1695/1696 |
| SECF3153 | 2000-03-31 | 9999-12-31 | LESS:TREASURY STOCK | SEC 1695/1696 |
| SECF3210 | 2000-03-31 | 9999-12-31 | TOTAL EQUITY CAPITAL | SEC 1695/1696 |
| SECF3230 | 2000-03-31 | 9999-12-31 | COMMON STOCK | SEC 1695/1696 |
| SECF3240 | 2000-03-31 | 9999-12-31 | SURPLUS | SEC 1695/1696 |
| SECF3247 | 2000-03-31 | 9999-12-31 | UNDIVIDED PROFITS AND CAPITAL RESERVES (RETAINED EARNINGS) | SEC 1695/1696 |
| SECF3283 | 2000-03-31 | 9999-12-31 | PERPETUAL PREFERRED STOCK (INCLUDING RELATED SURPLUS) | SEC 1695/1696 |
| SECF3300 | 2000-03-31 | 9999-12-31 | TOTAL LIABILITIES, LIMITED-LIFE PREFERRED STOCK, AND EQUITY CAPITAL | SEC 1695/1696 |
| SECF4073 | 2000-03-31 | 9999-12-31 | TOTAL INTEREST EXPENSE | SEC 1695/1696 |
| SECF4135 | 2000-03-31 | 9999-12-31 | SALARIES AND EMPLOYEE BENEFITS | SEC 1695/1696 |
| SECF4699 | 2000-03-31 | 9999-12-31 | RECEIVABLES FROM BROKERS, DEALERS, AND CLEARING ORGANIZATIONS | SEC 1695/1696 |
| SECF4747 | 2000-03-31 | 9999-12-31 | NET RECEIVABLES FROM CUSTOMERS | SEC 1695/1696 |
| SECF4827 | 2000-03-31 | 9999-12-31 | MEMBERSHIP IN EXCHANGES | SEC 1695/1696 |
| SECF5119 | 2000-03-31 | 9999-12-31 | TOTAL GROSS REVENUE | SEC 1695/1696 |
| SECF5125 | 2000-03-31 | 9999-12-31 | COMMISSIONS PAID TO BROKERS AND OTHERS | SEC 1695/1696 |
| SECF5127 | 2000-03-31 | 9999-12-31 | FLOOR BROKERAGE PAID TO BROKERS | SEC 1695/1696 |
| SECF5129 | 2000-03-31 | 9999-12-31 | LOSSES IN ERROR ACCOUNT AND BAD DEBTS | SEC 1695/1696 |
| SECF5131 | 2000-03-31 | 9999-12-31 | COMMUNICATIONS AND DATA PROCESSING | SEC 1695/1696 |
| SECF5133 | 2000-03-31 | 9999-12-31 | OTHER EXPENSE | SEC 1695/1696 |
| SECF5135 | 2000-03-31 | 9999-12-31 | TOTAL EXPENSE | SEC 1695/1696 |
| SECF5137 | 2000-03-31 | 9999-12-31 | INCOME (LOSS) BEFORE TAXES AND UNDISTRIBUTED INCOME | SEC 1695/1696 |
| SECF5141 | 2000-03-31 | 9999-12-31 | EXTRAORDINARY ITEMS, NET OF TAX EFFECT | SEC 1695/1696 |
| SECF5144 | 2000-03-31 | 9999-12-31 | EQUITY IN UNDISTRIBUTED INCOME (LOSSES) OF UNCONSOLIDATED SUBSIDIARIES AND ASSOCIATED COMPANIES | SEC 1695/1696 |
| SECF5145 | 2000-03-31 | 9999-12-31 | NET INCOME (LOSS) | SEC 1695/1696 |
| SECF5167 | 2000-03-31 | 9999-12-31 | SECURITIES SOLD UNDER AGREEMENTS TO REPURCHASE | SEC 1695/1696 |
| SECF6827 | 2000-03-31 | 9999-12-31 | EQUITY CAPITAL - BEGINNING BALANCE | SEC 1695/1696 |
| SECF7267 | 2000-03-31 | 9999-12-31 | PERCENTAGE OF AGGREGATE INDEBTEDNESS TO NET CAPITAL | SEC 1695/1696 |
| SECF7268 | 2000-03-31 | 9999-12-31 | PERCENTAGE OF AGGREGATE INDEBTEDNESS TO NET CAPITAL AFTER ANTICIPATED CAPITAL WITHDRAWALS | SEC 1695/1696 |
| SECF7269 | 2000-03-31 | 9999-12-31 | PERCENTAGE OF NET CAPITAL TO AGGREGATE DEBITS | SEC 1695/1696 |
| SECF7270 | 2000-03-31 | 9999-12-31 | PERCENTAGE OF NET CAPITAL AFTER ANTICIPATING CAPITAL WITHDRAWN TO AGGREGATE DEBITS | SEC 1695/1696 |
| SECF7271 | 2000-03-31 | 9999-12-31 | PERCENTAGE OF DEBT TO DEBT-EQUITY TOTAL COMPUTED IN ACCORDANCE WITH RULE 15C3-1 (D) | SEC 1695/1696 |
| SECF7272 | 2000-03-31 | 9999-12-31 | OPTIONS DEDUCTIONS/NET CAPITAL RATIO (1000% TEST) TOTAL DEDUCTIONS EXCLUSIVE OF LIQUIDATING EQUITY UNDER RULE 15C-1(A)(6), (A)(7) AND (C)(2)(X)/ NET CAPITAL | SEC 1695/1696 |
| SECF9005 | 2021-10-06 | 9999-12-31 | COUNTRY NAME | SEC 1695/1696 |
| SECF9028 | 2000-03-31 | 9999-12-31 | PHYSICAL FIRST STREET LINE | SEC 1695/1696 |
| SECF9123 | 2000-03-31 | 9999-12-31 | NAME - CONTACTS | SEC 1695/1696 |
| SECF9126 | 2000-03-31 | 9999-12-31 | TELEPHONE NUMBER - CONTACTS | SEC 1695/1696 |
| SECF9130 | 2000-03-31 | 9999-12-31 | CITY/TOWN TEXT NAME | SEC 1695/1696 |
| SECF9210 | 2000-03-31 | 9999-12-31 | PHYSICAL STATE CODE | SEC 1695/1696 |
| SECF9220 | 2000-03-31 | 9999-12-31 | PHYSICAL ZIP/FOREIGN MAILING CODE | SEC 1695/1696 |
| SECF9804 | 2000-03-31 | 9999-12-31 | TYPE OF REPORT FILED | SEC 1695/1696 |
| SECFB152 | 2000-03-31 | 9999-12-31 | AGED SHORT SECURITY DIFFERENCES-LESS: RESERVE OF (NET) | SEC 1695/1696 |
| SECFB153 | 2000-03-31 | 9999-12-31 | AMOUNT HELD ON DEPOSIT IN "RESERVE BANK ACCOUNT(S)," INCLUDING VALUE OF QUALIFIED SECURITIES, AT END OF REPORTING PERIOD | SEC 1695/1696 |
| SECFB165 | 2000-03-31 | 9999-12-31 | DOES RESPONDENT CARRY ITS OWN CUSTOMER ACCOUNT? YES | SEC 1695/1696 |
| SECFB166 | 2000-03-31 | 9999-12-31 | DOES RESPONDENT CARRY ITS OWN CUSTOMER ACCOUNT? NO | SEC 1695/1696 |
| SECFB167 | 2000-03-31 | 9999-12-31 | CASH | SEC 1695/1696 |
| SECFB168 | 2000-03-31 | 9999-12-31 | CASH SEGREGRATED IN COMPLIANCE WITH FEDERAL AND OTHER REGULATIONS | SEC 1695/1696 |
| SECFB170 | 2000-03-31 | 9999-12-31 | RECEIVABLE FROM-FAILED TO DELIVER: OTHER | SEC 1695/1696 |
| SECFB172 | 2000-03-31 | 9999-12-31 | RECEIVABLE FROM-SECURITIES BORROWED: OTHER | SEC 1695/1696 |
| SECFB174 | 2000-03-31 | 9999-12-31 | RECEIVABLE FROM-OMNIBUS ACCOUNTS: OTHER | SEC 1695/1696 |
| SECFB176 | 2000-03-31 | 9999-12-31 | RECEIVABLE FROM-CLEARING ORGANIZATIONS: OTHER | SEC 1695/1696 |
| SECFB180 | 2000-03-31 | 9999-12-31 | RECEIVABLES FROM NON-CUSTOMERS: PARTLY SECURED AND UNSECURED ACCOUNTS | SEC 1695/1696 |
| SECFB187 | 2000-03-31 | 9999-12-31 | SPORT COMMODITIES | SEC 1695/1696 |
| SECFB188 | 2000-03-31 | 9999-12-31 | SECURITIES OWNED NOT READILY MARKETABLE: AT COST | SEC 1695/1696 |
| SECFB189 | 2000-03-31 | 9999-12-31 | OTHER INVESTMENTS NOT READILY MARKETABLE: AT COST | SEC 1695/1696 |
| SECFB190 | 2000-03-31 | 9999-12-31 | OTHER INVESTMENTS NOT READILY MARKETABLE: AT ESTIMATED FAIR VALUE | SEC 1695/1696 |
| SECFB191 | 2000-03-31 | 9999-12-31 | SECURITIES BORROWED UNDER SUBORDINATION AGREEMENTS AND PARTNERS' INDIVIDUAL AND CAPITAL SECURITIES ACCOUNTS, AT MARKET VALUE: EXEMPTED SECURITIES | SEC 1695/1696 |
| SECFB192 | 2000-03-31 | 9999-12-31 | SECURITIES BORROWED UNDER SUBORDINATION AGREEMENTS AND PARTNERS' INDIVIDUAL AND CAPITAL SECURITIES ACCOUNTS, AT MARKET VALUE | SEC 1695/1696 |
| SECFB193 | 2000-03-31 | 9999-12-31 | SECURED DEMAND NOTES MARKET VALUE OF COLLATERAL: EXEMPTED SECURITIES | SEC 1695/1696 |
| SECFB194 | 2000-03-31 | 9999-12-31 | SECURED DEMAND NOTES MARKET VALUE OF COLLATERAL | SEC 1695/1696 |
| SECFB195 | 2000-03-31 | 9999-12-31 | MEMBERSHIPS IN EXCHANGES: OWNED AT MARKET VALUE | SEC 1695/1696 |
| SECFB200 | 2000-03-31 | 9999-12-31 | BANK LOANS PAYABLE: INCLUDABLE IN "FORMULA FOR RESERVE REQUIREMENTS | SEC 1695/1696 |
| SECFB201 | 2000-03-31 | 9999-12-31 | BANK LOANS PAYABLE: OTHER | SEC 1695/1696 |
| SECFB202 | 2000-03-31 | 9999-12-31 | PAYLABLE TO-FAILLED TO RECEIVE: INCLUDABLE IN "FORMULA FOR RESERVE REQUIEMENTS" | SEC 1695/1696 |
| SECFB203 | 2000-03-31 | 9999-12-31 | PAYABLE TO-FAILED TO RECEIVE: OTHER | SEC 1695/1696 |
| SECFB204 | 2000-03-31 | 9999-12-31 | PAYABLE TO-SECURITIES LOANED: INCLUDABLE IN "FORMULA FOR RESERVE REQUIREMENTS" | SEC 1695/1696 |
| SECFB205 | 2000-03-31 | 9999-12-31 | PAYABLE TO-SECURITIES LOANED: OTHER | SEC 1695/1696 |
| SECFB206 | 2000-03-31 | 9999-12-31 | PAYABLE TO-OMNIBUS ACCOUNTS: INCLUDABLE IN "FORMULA FOR RESERVE REQUIREMENTS" | SEC 1695/1696 |
| SECFB207 | 2000-03-31 | 9999-12-31 | PAYABLE TO-OMNIBUS ACCOUNTS: OTHER | SEC 1695/1696 |
| SECFB208 | 2000-03-31 | 9999-12-31 | PAYABLE TO-CLEARING ORGANIZATIONS: INCLUDABLE IN "FORMULA FOR RESERVE REQUIREMENTS" | SEC 1695/1696 |
| SECFB209 | 2000-03-31 | 9999-12-31 | PAYABLE TO-CLEARING ORGANIZATIONS: OTHER | SEC 1695/1696 |
| SECFB210 | 2000-03-31 | 9999-12-31 | PAYABLE TO BROKERS OR DEALERS AND CLEARAING ORGANIZATIONS: OTHER | SEC 1695/1696 |
| SECFB211 | 2000-03-31 | 9999-12-31 | PAYABLE TO CUSTOMERS: SECURITIES ACCOUNTS-INCLUDING FREE CREDITS | SEC 1695/1696 |
| SECFB212 | 2000-03-31 | 9999-12-31 | PAYABLE TO CUSTOMERS: COMMODITIES ACCOUNTS | SEC 1695/1696 |
| SECFB213 | 2000-03-31 | 9999-12-31 | PAYABLE TO NON CUSTOMERS: SECURITIES ACCOUNTS | SEC 1695/1696 |
| SECFB214 | 2000-03-31 | 9999-12-31 | PAYABLE TO NON CUSTOMERS: COMMODITIES ACCOUNTS | SEC 1695/1696 |
| SECFB215 | 2000-03-31 | 9999-12-31 | SECURITIES SOLD NOT YET PURCHASED AT MARKET VALUE-INCLUDING ARBITRAGE | SEC 1695/1696 |
| SECFB216 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE AND ACCURED LIABILITIES AND EXPENSES: DRAFTS PAYABLE | SEC 1695/1696 |
| SECFB217 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE AND ACCURED LIABILITIES AND EXPENSES: ACCOUNTS PAYABLE | SEC 1695/1696 |
| SECFB218 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE AND ACCURED LIABILITIES AND EXPENSES: INCOME TAXES PAYABLE | SEC 1695/1696 |
| SECFB219 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE AND ACCURED LIABILITIES AND EXPENSES: DEFERRED INCOME TAXES | SEC 1695/1696 |
| SECFB220 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE AND ACCURED LIABILITIES AND EXPENSES: ACCURED EXPENSES AND OTHER LIABILITIES | SEC 1695/1696 |
| SECFB221 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE AND ACCURED LIABILITIES AND EXPENSES: OTHER | SEC 1695/1696 |
| SECFB222 | 2000-03-31 | 9999-12-31 | NOTES AND MORTGAGES PAYABLE: UNSECURED | SEC 1695/1696 |
| SECFB223 | 2000-03-31 | 9999-12-31 | NOTES AND MORTGAGES PAYABLE: SECURED | SEC 1695/1696 |
| SECFB224 | 2000-03-31 | 9999-12-31 | LIABILITIES SUBORDINATED TO CLAIMS OF GENERAL CREDITORS: CASH BORROWINGS | SEC 1695/1696 |
| SECFB225 | 2000-03-31 | 9999-12-31 | LIABILITIES SUBORDINATED TO CLAIMS OF GENERAL CREDITORS - CASH BORROWINGS: FROM OUTSIDERS | SEC 1695/1696 |
| SECFB226 | 2000-03-31 | 9999-12-31 | LIABILITIES SUBORDINATED TO CLAIMS OF GENERAL CREDITORS - CASH BORROWING: INCLUDES EQUITY SUBORDINATION (15C3-1(D) OF | SEC 1695/1696 |
| SECFB227 | 2000-03-31 | 9999-12-31 | SECURITIES BORROWINGS, AT MARKET VALUE | SEC 1695/1696 |
| SECFB228 | 2000-03-31 | 9999-12-31 | SECURITIES BORROWINGS, AT MARKET VALUE FROM OUTSIDERS | SEC 1695/1696 |
| SECFB229 | 2000-03-31 | 9999-12-31 | PURSUANT TO SECURED DEMAND NOTE COLLATERAL AGREEMENTS | SEC 1695/1696 |
| SECFB230 | 2000-03-31 | 9999-12-31 | PURSUANT TO SECURED DEMAND NOTE COLLATERAL AGREEMENTS: FROM OUTSIDERS | SEC 1695/1696 |
| SECFB231 | 2000-03-31 | 9999-12-31 | PURSUANT TO SECURED DEMAND NOTE COLLATERAL AGREEMENTS: INCLUDES EQUITY SUBORDINATION (15C-3-1(D)) OF | SEC 1695/1696 |
| SECFB232 | 2000-03-31 | 9999-12-31 | EXCHANGE MEMBERSHIPS CONTRIBUTED FOR USE OF COMPANY, AT MARKET VALUE | SEC 1695/1696 |
| SECFB233 | 2000-03-31 | 9999-12-31 | ACCOUNTS AND OTHER BORROWINGS NOT QUALIFIED FOR NET CAPITAL PURPOSES | SEC 1695/1696 |
| SECFB234 | 2000-03-31 | 9999-12-31 | OWNERSHIP EQUITY: SOLE PROPRIETORSHIP | SEC 1695/1696 |
| SECFB235 | 2000-03-31 | 9999-12-31 | OWNERSHIP EQUITY: PARTNERSHIP-LIMITED PARTNERS | SEC 1695/1696 |
| SECFB236 | 2000-03-31 | 9999-12-31 | OWNERSHIP EQUITY-CORPORATION: TOTAL | SEC 1695/1696 |
| SECFB237 | 2000-03-31 | 9999-12-31 | DEDUCT: OWNERSHIP EQUITY NOT ALLOWABLE FOR NET CAPITAL | SEC 1695/1696 |
| SECFB238 | 2000-03-31 | 9999-12-31 | TOTAL OWNERSHIP EQUITY QUALIFIED FOR NET CAPITAL | SEC 1695/1696 |
| SECFB239 | 2000-03-31 | 9999-12-31 | ADD: LIABILITIES SUBORDINATED TO CLAIMS OF GENERAL CREDITORS ALLOWABLE IN COMPUTATION OF NET CAPITAL | SEC 1695/1696 |
| SECFB240 | 2000-03-31 | 9999-12-31 | OTHER (DEDUCTIONS) OR ALLOWABLE CREDITS (LIST) | SEC 1695/1696 |
| SECFB241 | 2000-03-31 | 9999-12-31 | TOTAL CAPITAL AND ALLOWABLE SUBORDINATED LIABILITIES | SEC 1695/1696 |
| SECFB242 | 2000-03-31 | 9999-12-31 | DEDUCTIONS AND/OR CHARGES:TOTAL NONALLOWABLE ASSETS FROM STATEMENT OF FINANCIAL CONDITION (NOTES B AND C) | SEC 1695/1696 |
| SECFB243 | 2000-03-31 | 9999-12-31 | ADDITIONAL CHARGES FOR CUSTOMERS' AND NON-CUSTOMERS; SECURITY ACCOUNTS | SEC 1695/1696 |
| SECFB244 | 2000-03-31 | 9999-12-31 | ADDITIONAL CHARGES FOR CUSTOMERS' AND NON-CUSTOMERS' COMMODITY ACCOUNTS | SEC 1695/1696 |
| SECFB245 | 2000-03-31 | 9999-12-31 | DEDUCTIONS AND/OR CHARGES: AGED FAIL-TO-DELIVER | SEC 1695/1696 |
| SECFB246 | 2000-03-31 | 9999-12-31 | AGED FAIL-TO-DELIVER: NUMBER OF ITEMS | SEC 1695/1696 |
| SECFB247 | 2000-03-31 | 9999-12-31 | AGED SHORT SECURITY DIFFERENCES-LESS: RESERVE OF | SEC 1695/1696 |
| SECFB248 | 2000-03-31 | 9999-12-31 | AGED SHORT SECURITY DIFFERENCES-LESS: NUMBER OF ITEMS | SEC 1695/1696 |
| SECFB249 | 2000-03-31 | 9999-12-31 | SECURED DEMAND NOTE DEFICIENCY | SEC 1695/1696 |
| SECFB250 | 2000-03-31 | 9999-12-31 | COMMODITY FUTURES CONTRACTS AND SPOT COMMODITIES - PROPRIETARY CAPITAL CHARGES | SEC 1695/1696 |
| SECFB251 | 2000-03-31 | 9999-12-31 | OTHER DEDUCTIONS AND/OR CHARGES | SEC 1695/1696 |
| SECFB252 | 2000-03-31 | 9999-12-31 | DEDUCTIONS FOR ACCOUNTS CARRIED UNDER RULE 15C3-1(A)(6),(A)(7) AND (C)(2)(X) | SEC 1695/1696 |
| SECFB253 | 2000-03-31 | 9999-12-31 | TOTAL DEDUCTIONS AND/OR CHARGES | SEC 1695/1696 |
| SECFB254 | 2000-03-31 | 9999-12-31 | OTHER ADDITIONS AND/OR ALLOWABLE CREDITS (LIST) | SEC 1695/1696 |
| SECFB255 | 2000-03-31 | 9999-12-31 | NET CAPITAL BEFORE HAIRCUTS ON SECURITIES POSITIONS | SEC 1695/1696 |
| SECFB256 | 2000-03-31 | 9999-12-31 | HAIRCUTS ON SECURITIES: CONTRACTUAL SECURITIES COMMITMENTS | SEC 1695/1696 |
| SECFB257 | 2000-03-31 | 9999-12-31 | HAIRCUTS ON SECURITIES: SUBORDINATED SECURITIES BORROWINGS | SEC 1695/1696 |
| SECFB258 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: BANKERS' ACCEPTANCES, CERTIFICATES OF DEPOSIT AND COMMERCIAL PAPER | SEC 1695/1696 |
| SECFB259 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: U.S. AND CANADIAN GOVERNMENT OBLIGATIONS | SEC 1695/1696 |
| SECFB260 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: STATE AND MUNICIPAL GOVERNMENT OBLIGATIONS | SEC 1695/1696 |
| SECFB261 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: CORPORATE OBLIGATIONS | SEC 1695/1696 |
| SECFB262 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENTS SECURITIES: STOCKS AND WARRANTS | SEC 1695/1696 |
| SECFB263 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: OPTIONS | SEC 1695/1696 |
| SECFB264 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: ARBITRAGE | SEC 1695/1696 |
| SECFB265 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: OTHER SECURITIES | SEC 1695/1696 |
| SECFB266 | 2000-03-31 | 9999-12-31 | UNDUE CONCENTRATION | SEC 1695/1696 |
| SECFB267 | 2000-03-31 | 9999-12-31 | HAIRCUTS ON SECURITIES: OTHER (LIST) | SEC 1695/1696 |
| SECFB268 | 2000-03-31 | 9999-12-31 | HAIRCUTS ON SECURITIES: TOTAL | SEC 1695/1696 |
| SECFB269 | 2000-03-31 | 9999-12-31 | NET CAPITAL | SEC 1695/1696 |
| SECFB270 | 2000-03-31 | 9999-12-31 | MINIMUM NET CAPITAL REQUIRED | SEC 1695/1696 |
| SECFB272 | 2000-03-31 | 9999-12-31 | NET CAPITAL REQUIREMENT | SEC 1695/1696 |
| SECFB273 | 2000-03-31 | 9999-12-31 | EXCESS NET CAPITAL | SEC 1695/1696 |
| SECFB274 | 2000-03-31 | 9999-12-31 | EXCESS NET CAPITAL AT 1000% | SEC 1695/1696 |
| SECFB275 | 2000-03-31 | 9999-12-31 | DRAFTS FOR IMMEDIATE CREDIT | SEC 1695/1696 |
| SECFB276 | 2000-03-31 | 9999-12-31 | MARKET VALUE OF SECURITIES BORROWED FOR WHICH NO EQUIVALENT VALUE IS PAID OR CREDITED | SEC 1695/1696 |
| SECFB277 | 2000-03-31 | 9999-12-31 | OTHER UNRECORDED AMOUNTS (LIST) | SEC 1695/1696 |
| SECFB278 | 2000-03-31 | 9999-12-31 | TOTAL OF: DRAFTS FOR IMMEDIATE CREDIT, MARKET VALUE O SECURITIES BORROWED FOR WHICH NO EQUIVALENT VALUE IS PAID OR CREDITED, OTHER UNRECORDED AMOUNTS | SEC 1695/1696 |
| SECFB279 | 2000-03-31 | 9999-12-31 | ADJUSTMENT BASED ON DEPOSITS IN SPECIAL RESERVE BANK ACCOUNTS | SEC 1695/1696 |
| SECFB280 | 2000-03-31 | 9999-12-31 | TOTAL AGGREGATE INDEBTEDNESS | SEC 1695/1696 |
| SECFB283 | 2000-03-31 | 9999-12-31 | 2% OF COMBINED AGGREGATE DEBIT ITEMS AS SHOWN IN FORMULA FOR RESERVE REQUIREMENTS PURSUANT TO RULE 15C3-3 PREPARED AS OF THE DATE OF THE NET CAPITAL COMPUTATION INCLUDING BOTH BROKERS OR DEALERS AND CONSOLIDATED SUBSIDIARIES DEBITS | SEC 1695/1696 |
| SECFB284 | 2000-03-31 | 9999-12-31 | NET CAPITAL REQUIREMENT (GREATER LINE 22 OR 23) | SEC 1695/1696 |
| SECFB285 | 2000-03-31 | 9999-12-31 | EXCESS NET CAPITAL (LINE 10 LESS 24) | SEC 1695/1696 |
| SECFB287 | 2000-03-31 | 9999-12-31 | ACCOUNTS PAYABLE, ACCRUED LIABILITIES, EXPENSES AND OTHER | SEC 1695/1696 |
| SECFB288 | 2000-03-31 | 9999-12-31 | NET CAPITAL IN EXCESS OF THE GREATER OF: 5% OF COMBINED AGGREGATE DEBIT ITEMS OR $120,000 | SEC 1695/1696 |
| SECFB289 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: EXEMPTED SECURITIES | SEC 1695/1696 |
| SECFB290 | 2000-03-31 | 9999-12-31 | TRADING AND INVESTMENT SECURITIES: DEBT SECURITIES | SEC 1695/1696 |
| SECFB291 | 2000-03-31 | 9999-12-31 | NUMBER OF MONTHS INCLUDED IN THIS STATEMENT | SEC 1695/1696 |
| SECFB292 | 2000-03-31 | 9999-12-31 | COMMISSIONS ON TRANSACTIONS IN LISTED EQUITY SECURITIES EXECUTED ON AN EXCHANGE | SEC 1695/1696 |
| SECFB293 | 2000-03-31 | 9999-12-31 | COMMISSIONS ON TRANSACTIONS IN EXCHANGE LISTED EQUITY SECURITIES EXECUTED OVER-THE-COUNTER | SEC 1695/1696 |
| SECFB294 | 2000-03-31 | 9999-12-31 | COMMISSIONS ON LISTED OPTIONS TRANSACTIONS | SEC 1695/1696 |
| SECFB295 | 2000-03-31 | 9999-12-31 | ALL OTHER SECURITIES COMMISSIONS | SEC 1695/1696 |
| SECFB296 | 2000-03-31 | 9999-12-31 | TOTAL SECURITIES COMMISSIONS | SEC 1695/1696 |
| SECFB297 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRMS SECURITIES TRADING ACCOUNTS: FROM MARKET MAKING IN OVER-THE-COUNTER EQUITY SECURITIES | SEC 1695/1696 |
| SECFB298 | 2000-03-31 | 9999-12-31 | INCLUDES GAINS OR (LOSSES) OTC MARKET IN EXCHANGE LISTED EQUITY SECURITIES | SEC 1695/1696 |
| SECFB299 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS: FROM TRADING IN DEBT SECURITIES | SEC 1695/1696 |
| SECFB300 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS: FROM MARKET MAKING IN OPTIONS ON A NATIONAL SECURITIES EXCHANGE | SEC 1695/1696 |
| SECFB301 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS: FROM ALL OTHER TRADING | SEC 1695/1696 |
| SECFB302 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS: TOTAL GAINS OR (LOSSES) | SEC 1695/1696 |
| SECFB303 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES INVESTMENT ACCOUNTS: INCLUDES REALIZED GAINS (LOSSES) | SEC 1695/1696 |
| SECFB304 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES INVESTMENT ACCOUNTS: INCLUDES UNREALIZED GAINS (LOSSES) | SEC 1695/1696 |
| SECFB305 | 2000-03-31 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES INVESTMENT ACCOUNTS: TOTAL REALIZED AND UNREALIZED GAINS (LOSSES) | SEC 1695/1696 |
| SECFB306 | 2000-03-31 | 9999-12-31 | PROFITS OR (LOSSES) FROM UNDERWRITING AND SELLING GROUPS | SEC 1695/1696 |
| SECFB307 | 2000-03-31 | 9999-12-31 | INCLUDES UNDERWRITING INCOME FROM CORPORATE EQUITY SECURITIES | SEC 1695/1696 |
| SECFB308 | 2000-03-31 | 9999-12-31 | MARGIN INTEREST | SEC 1695/1696 |
| SECFB309 | 2000-03-31 | 9999-12-31 | REVENUE FROM SALE OF INVESTMENT COMPANY SHARES | SEC 1695/1696 |
| SECFB310 | 2000-03-31 | 9999-12-31 | FEES FOR ACCOUNT SUPERVISION, INVESTMENT ADVISORY AND ADMINISTRATIVE SERVICES | SEC 1695/1696 |
| SECFB311 | 2000-03-31 | 9999-12-31 | REVENUE FROM RESEARCH SERVICES | SEC 1695/1696 |
| SECFB312 | 2000-03-31 | 9999-12-31 | COMMODITIES REVENUE | SEC 1695/1696 |
| SECFB313 | 2000-03-31 | 9999-12-31 | OTHER REVENUE RELATED TO SECURITIES BUSINESS | SEC 1695/1696 |
| SECFB314 | 2000-03-31 | 9999-12-31 | OTHER REVENUE | SEC 1695/1696 |
| SECFB315 | 2000-03-31 | 9999-12-31 | REGISTERED REPRESENTATIVES' COMPENSATION | SEC 1695/1696 |
| SECFB316 | 2000-03-31 | 9999-12-31 | CLERICAL AND ADMINISTRATIVE EMPLOYEES' EXPENSES | SEC 1695/1696 |
| SECFB317 | 2000-03-31 | 9999-12-31 | INCLUDES INTEREST CREDITED TO GENERAL AND LIMITED PARTNERS CAPITAL ACCOUNTS | SEC 1695/1696 |
| SECFB318 | 2000-03-31 | 9999-12-31 | CLEARANCE PAID TO NON-BROKERS | SEC 1695/1696 |
| SECFB319 | 2000-03-31 | 9999-12-31 | COMMUNICATIONS | SEC 1695/1696 |
| SECFB320 | 2000-03-31 | 9999-12-31 | OCCUPANCY AND EQUIPMENT COSTS | SEC 1695/1696 |
| SECFB321 | 2000-03-31 | 9999-12-31 | PROMOTIONAL COSTS | SEC 1695/1696 |
| SECFB322 | 2000-03-31 | 9999-12-31 | INCLUDES INTEREST ON ACCOUNTS SUBJECT TO SUBORDINATION AGREEMENTS | SEC 1695/1696 |
| SECFB323 | 2000-03-31 | 9999-12-31 | NON-RECURRING CHARGES | SEC 1695/1696 |
| SECFB324 | 2000-03-31 | 9999-12-31 | REGULATORY FEES AND EXPENSES | SEC 1695/1696 |
| SECFB325 | 2000-03-31 | 9999-12-31 | PROVISION FOR FEDERAL INCOME TAXES | SEC 1695/1696 |
| SECFB326 | 2000-03-31 | 9999-12-31 | EQUITY IN EARNINGS (LOSSES) OF UNCONSOLIDATED SUBSIDIARIES NOT INCLUDED ABOVE | SEC 1695/1696 |
| SECFB327 | 2000-03-31 | 9999-12-31 | AFTER FEDERAL INCOME TAXES OF | SEC 1695/1696 |
| SECFB328 | 2000-03-31 | 9999-12-31 | CUMULATIVE EFFECT OF CHANGES IN ACCOUNTING PRINCIPALS | SEC 1695/1696 |
| SECFB329 | 2000-03-31 | 9999-12-31 | INCOME (CURRENT MONTH ONLY) BEFORE PROVISION FOR FEDERAL INCOME TAXES AND EXTRAORDINARY ITEMS | SEC 1695/1696 |
| SECFB330 | 2000-03-31 | 9999-12-31 | FREE CREDIT BALANCES AND OTHER CREDIT BALANCES IN CUSTOMERS' SECURITY ACCOUNTS | SEC 1695/1696 |
| SECFB331 | 2000-03-31 | 9999-12-31 | MONIES BORROWED COLLATERALIZED BY SECURITIES CARRIED FOR THE ACCOUNTS OF CUSTOMERS | SEC 1695/1696 |
| SECFB332 | 2000-03-31 | 9999-12-31 | MONIES PAYABLE AGAINST CUSTOMERS' SECURITIES LOANED | SEC 1695/1696 |
| SECFB333 | 2000-03-31 | 9999-12-31 | CUSTOMERS' SECURITIES FAILED TO RECEIVE | SEC 1695/1696 |
| SECFB334 | 2000-03-31 | 9999-12-31 | CREDIT BALANCES IN FIRM ACCOUNTS WHICH ARE ATTRIBUTABLE TO PRINCIPAL SALES TO CUSTOMERS | SEC 1695/1696 |
| SECFB335 | 2000-03-31 | 9999-12-31 | MARKET VALUE OF STOCK DIVIDENDS, STOCK SPLITS AND SIMILAR DISTRIBUTIONS RECEIVABLE OUTSTANDING OVER 30 CALENDAR DAYS | SEC 1695/1696 |
| SECFB336 | 2000-03-31 | 9999-12-31 | MARKET VALUE OF SHORT SECURITY COUNT DIFFERENCES OVER 30 CALENDAR DAYS OLD | SEC 1695/1696 |
| SECFB337 | 2000-03-31 | 9999-12-31 | MARKET VALUE OF SHORT SECURITIES AND CREDITS (NOT TO BE OFFSET BY LONGS OR BY DEBITS) IN ALL SUSPENSE ACCOUNTS OVER 30 CALENDAR DAYS | SEC 1695/1696 |
| SECFB338 | 2000-03-31 | 9999-12-31 | MARKET VALUE OF SECURITIES WHICH ARE IN TRANSFER IN EXCESS OF 40 CALENDAR DAYS AND HAVE NOT BEEN CONFIRMED TO BE IN TRANSFER BY THE TRANSFER AGENT OR THE ISSUER DURING THE 40 DAYS | SEC 1695/1696 |
| SECFB339 | 2000-03-31 | 9999-12-31 | CREDIT BALANCES: OTHER (LIST) | SEC 1695/1696 |
| SECFB340 | 2000-03-31 | 9999-12-31 | DEBIT BALANCES IN CUSTOMERS' CASH AND MARGIN ACCOUNTS EXCLUDING UNSECURED ACCOUNTS AND ACCOUNTS DOUBTFUL OF COLLECTION NOT OF DEDUCTIONS PURSUANT TO NOTE E, EXHIBIT A, RULE 15C3-3 | SEC 1695/1696 |
| SECFB341 | 2000-03-31 | 9999-12-31 | SECURITIES BORROWED TO EFFECTUATE SHORT SALES BY CUSTOMERS AND SECURITIES BORROWED TO MAKE DELIVERY ON CUSTOMERS' SECURITIES FAILED TO DELIVER | SEC 1695/1696 |
| SECFB342 | 2000-03-31 | 9999-12-31 | FAILED TO DELIVER OF CUSTOMERS' SECURITIES NOT OLDER THAN 30 CALENDAR DAYS | SEC 1695/1696 |
| SECFB343 | 2000-03-31 | 9999-12-31 | MARGIN REQUIRED AND ON DEPOSIT WITH OPTIONS CLEARING CORPORATION FOR ALL OPTION CONTRACTS WRITTEN OR PURCHASED IN CUSTOMER ACCOUNTS | SEC 1695/1696 |
| SECFB344 | 2000-03-31 | 9999-12-31 | DEBIT BALANCES: OTHER (LIST) | SEC 1695/1696 |
| SECFB345 | 2000-03-31 | 9999-12-31 | AGGREGATE DEBIT ITEMS | SEC 1695/1696 |
| SECFB346 | 2000-03-31 | 9999-12-31 | LESS 3% | SEC 1695/1696 |
| SECFB347 | 2000-03-31 | 9999-12-31 | TOTAL 15C3-3 DEBITS | SEC 1695/1696 |
| SECFB348 | 2000-03-31 | 9999-12-31 | EXCESS OF TOTAL DEBITS OVER TOTAL CREDITS | SEC 1695/1696 |
| SECFB349 | 2000-03-31 | 9999-12-31 | EXCESS OF TOTAL CREDITS OVER TOTAL DEBITS | SEC 1695/1696 |
| SECFB350 | 2000-03-31 | 9999-12-31 | IF COMPUTATAION PERMITTED ON A MONTHLY BASIS, ENTER 105% OF EXCESS OF TOTAL CREDITS OVER TOTAL DEBITS | SEC 1695/1696 |
| SECFB351 | 2000-03-31 | 9999-12-31 | AMOUNT OF DEPOSIT (OR WITHDRAWAL) INCLUDING | SEC 1695/1696 |
| SECFB352 | 2000-03-31 | 9999-12-31 | AMOUNT OF DEPOSIT (OR WITHDRAWAL) INCLUDING VALUE OF QUALIFIED SECURITIES | SEC 1695/1696 |
| SECFB353 | 2000-03-31 | 9999-12-31 | NEW AMOUNT IN RESERVE BANK ACCOUNT(S) AFTER ADDING DEPOSIT OR SUBTRACTING WITHDRAWAL INCLUDING | SEC 1695/1696 |
| SECFB354 | 2000-03-31 | 9999-12-31 | NEW AMOUNT IN RESERVE BANK ACCOUNT(S) AFTER ADDING DEPOSIT OR SUBTRACTING WITHDRAWAL INCLUDING VALUE OF QUALIFIED SECURITIES | SEC 1695/1696 |
| SECFB355 | 2000-03-31 | 9999-12-31 | DATE OF DEPOSIT | SEC 1695/1696 |
| SECFB356 | 2000-03-31 | 9999-12-31 | FREQUENCY OF COMPUTATION: DAILY | SEC 1695/1696 |
| SECFB357 | 2000-03-31 | 9999-12-31 | FREQUENCY OF COMPUTATION: WEEKLY | SEC 1695/1696 |
| SECFB358 | 2000-03-31 | 9999-12-31 | FREQUENCY OF COMPUTATION: MONTHLY | SEC 1695/1696 |
| SECFB359 | 2000-03-31 | 9999-12-31 | $2500 CAPITAL CATEGORY AS PER RULE 15C3-1 | SEC 1695/1696 |
| SECFB360 | 2000-03-31 | 9999-12-31 | "SPECIAL ACCOUNT FOR THE EXCLUSIVE BENEFITS OF CUSTOMERS" MAINTAINED | SEC 1695/1696 |
| SECFB361 | 2000-03-31 | 9999-12-31 | ALL CUSTOMER TRANSACTIONS CLEARED THROUGH ANOTHER BROKER-DEALER ON A FULLY DISCLOSED BASIS: NAME OF CLEARING FIRM | SEC 1695/1696 |
| SECFB362 | 2000-03-31 | 9999-12-31 | ALL CUSTOMER TRANSACTIONS CLEARED THROUGH ANOTHER BROKER-DEALER ON A FULLY DISCLOSED BASIS: VALUE | SEC 1695/1696 |
| SECFB363 | 2000-03-31 | 9999-12-31 | EXEMPTED BY ORDER OF THE COMMISSION | SEC 1695/1696 |
| SECFB364 | 2000-03-31 | 9999-12-31 | STATE THE MARKET VALUATION AND NUMBER OF: CUSTOMERS' FULLY PAID SECURITIES AND EXCESS MARGIN SECURITIES NOT IN THE RESPONDENT'S POSSESSION OR CONTROL AS OF REPORT DATE,ETC. | SEC 1695/1696 |
| SECFB365 | 2000-03-31 | 9999-12-31 | NUMBER OF ITEMS | SEC 1695/1696 |
| SECFB366 | 2000-03-31 | 9999-12-31 | STATE THE MARKET VALUATION AND NUMBER OF ITEMS OF: CUSTOMERS' FULLY PAID SECURITIES AND EXCESS MARGIN SECURITIES FOR WHICH INSTRUCTIONS TO REDUCE TO POSSESSION OR CONTROL HAD NOT BEEN ISSUED AS OF THE REPORT DATE, ETC. | SEC 1695/1696 |
| SECFB367 | 2000-03-31 | 9999-12-31 | NUMBER OF ITEMS | SEC 1695/1696 |
| SECFB368 | 2000-03-31 | 9999-12-31 | THE SYSTEM AND PROCEDURES UTILIZED IN COMPLYING WITH THE REQUIREMENT TO MAINTAIN PHYSICAL POSSESSION OR CONTROL OF CUSTOMERS' FULLY PAID AND EXCESS MARGIN SECURITIES HAVE BEEN TESTED AND ARE FUNCTIONING IN A MANNER TO FULFILL RQMNTS OF RULE 15C3-3: YES | SEC 1695/1696 |
| SECFB369 | 2000-03-31 | 9999-12-31 | THE SYSTEM AND PROCEDURES UTILIZED IN COMPLYING WITH THE REQUIREMENT TO MAINTAIN PHYSICAL POSSESSION OR CONTROL OF CUSTOMERS' FULLY PAID AND EXCESS MARGIN SECURITIES HAVE BEEN TESTED AND ARE FUNCTIONING IN A MANNER TO FULFILL RQMNTS OF RULE 15C3-3: NO | SEC 1695/1696 |
| SECFB370 | 2000-03-31 | 9999-12-31 | NET LEDGER BALANCE: CASH | SEC 1695/1696 |
| SECFB371 | 2000-03-31 | 9999-12-31 | NET LEDGER BALANCE: SECURITIES (AT MARKET) | SEC 1695/1696 |
| SECFB372 | 2000-03-31 | 9999-12-31 | NET UNREALIZED PROFIT (LOSS) IN OPEN FUTURES CONTRACTS TRADED ON A CONTRACT MARKET | SEC 1695/1696 |
| SECFB373 | 2000-03-31 | 9999-12-31 | EXCHANGE TRADED OPTIONS: ADD:MARKET VALUE OF OPEN OPTION CONTRACTS PURCHASED ON A CONTRACT MARKET | SEC 1695/1696 |
| SECFB374 | 2000-03-31 | 9999-12-31 | EXCHANGE TRADED OPTIONS:DEDUCT:MARKET VALUE OF OPEN OPTIONS CONTRACTS GRANTED (SOLD) ON A CONTRACT MARKET | SEC 1695/1696 |
| SECFB375 | 2000-03-31 | 9999-12-31 | NET EQUITY (DEFICIT)(TOTAL OF 1,2, AND 3) | SEC 1695/1696 |
| SECFB376 | 2000-03-31 | 9999-12-31 | ADD ACCOUNTS LIQUIDATING TO A DEFICIT AND ACCOUNTS WITH DEBIT BALANCES WITH NO OPEN TRADES | SEC 1695/1696 |
| SECFB377 | 2000-03-31 | 9999-12-31 | AMOUNT REQUIRED TO BE SEGREGATED | SEC 1695/1696 |
| SECFB378 | 2000-03-31 | 9999-12-31 | DEPOSITED IN SEGREGATED FUNDS BANK ACCOUNTS: CASH | SEC 1695/1696 |
| SECFB379 | 2000-03-31 | 9999-12-31 | DEPOSITED IN SEGREGATED FUNDS BANK ACCOUNTS: SECURITIES REPRESENTING INVESTMENTS OF CUSTOMERS' FUNDS (AT MARKET) | SEC 1695/1696 |
| SECFB380 | 2000-03-31 | 9999-12-31 | DEPOSITED IN SEGREGATED FUNDS BANK ACCOUNTS: SECURITIES HELD FOR PARTICULAR CUSTOMERS OR OPTION CUSTOMERS IN LIEU OF CASH (AT MARKET) | SEC 1695/1696 |
| SECFB381 | 2000-03-31 | 9999-12-31 | MARGINS ON DEPOSIT WITH CLEARING ORGANIZATIONS OF CONTRACT MARKETS: CASH | SEC 1695/1696 |
| SECFB382 | 2000-03-31 | 9999-12-31 | MARGINS ON DEPOSIT WITH CLEARING ORGANIZATIONS OF CONTRACT MARKETS: SECURITIES REPRESENTING INVESTMENTS OF CUSTOMERS' FUNDS (AT MARKET) | SEC 1695/1696 |
| SECFB383 | 2000-03-31 | 9999-12-31 | MARGINS ON DEPOSIT WITH CLEARING ORGANIZATIONS OF CONTRACT MARKETS: SECURITIES HELD FOR PARTICULAR CUSTOMERS OR OPTIONS IN LIEU OF CASH (AT MARKET) | SEC 1695/1696 |
| SECFB384 | 2000-03-31 | 9999-12-31 | SETTLEMENT DUE FROM (TO) CLEARING ORGANIZATIONS OF CONTRACT MARKETS | SEC 1695/1696 |
| SECFB385 | 2000-03-31 | 9999-12-31 | EXCHANGE TRADED OPTIONS: ADD:UNREALIZED RECEIVABLES FOR OPTIONS CONTRACTS PURCHASED ON CONTRACT MARKETS | SEC 1695/1696 |
| SECFB386 | 2000-03-31 | 9999-12-31 | EXCHANGE TRADED OPIONS: DEDUCT: UNREALIZED OBLIGATIONS FOR OPTION CONTRACTS GRANTED (SOLD) ON CONTRACT MARKETS | SEC 1695/1696 |
| SECFB387 | 2000-03-31 | 9999-12-31 | NET EQUITIES WITH OTHER FCMS | SEC 1695/1696 |
| SECFB388 | 2000-03-31 | 9999-12-31 | SEGREGATED FUNDS ON HAND: CASH | SEC 1695/1696 |
| SECFB389 | 2000-03-31 | 9999-12-31 | SEGREGATED FUNDS ON HAND:SECURITIES REPRESENTING INVESTMENTS OF CUSTOMERS' FUNDS (AT MARKET) | SEC 1695/1696 |
| SECFB390 | 2000-03-31 | 9999-12-31 | SEGREGATED FUNDS ON HAND: SECURITIES HELD FOR PARTICULAR CUSTOMERS IN LIEU OF CASH (AT MARKET) | SEC 1695/1696 |
| SECFB391 | 2000-03-31 | 9999-12-31 | TOTAL AMOUNT IN SEGREGATION (TOTAL OF 7 THROUH 12) | SEC 1695/1696 |
| SECFB392 | 2000-03-31 | 9999-12-31 | EXCESS (INSUFFICIENCY) FUNDS IN SEGREGATION (13 MINUS 6) | SEC 1695/1696 |
| SECFB393 | 2000-03-31 | 9999-12-31 | PARTNERSHIP CAPITAL: GENERAL PARTNERS | SEC 1695/1696 |
| SECFB394 | 2000-03-31 | 9999-12-31 | PARTNERSHIP CAPITAL: LIMITED | SEC 1695/1696 |
| SECFB395 | 2000-03-31 | 9999-12-31 | PARTNERSHIP CAPITAL: UNDISTRIBUTED PROFITS | SEC 1695/1696 |
| SECFB396 | 2000-03-31 | 9999-12-31 | PARTNERSHIP CAPITAL: OTHER | SEC 1695/1696 |
| SECFB397 | 2000-03-31 | 9999-12-31 | PARTNERSHIP CAPITAL: SOLE PROPRIETORSHIP | SEC 1695/1696 |
| SECFB398 | 2000-03-31 | 9999-12-31 | CORPORATION CAPITAL:COMMON STOCK | SEC 1695/1696 |
| SECFB399 | 2000-03-31 | 9999-12-31 | CORPORATION CAPITAL:PREFERRED STOCK | SEC 1695/1696 |
| SECFB400 | 2000-03-31 | 9999-12-31 | CORPORATION CAPITAL:RETAINED EARNINGS(DIVIDENDS AND OTHER) | SEC 1695/1696 |
| SECFB401 | 2000-03-31 | 9999-12-31 | CORPORATION CAPITAL: OTHER | SEC 1695/1696 |
| SECFB402 | 2000-03-31 | 9999-12-31 | SECURED DEMAND NOTES | SEC 1695/1696 |
| SECFB403 | 2000-03-31 | 9999-12-31 | CASH SUBORDINATES | SEC 1695/1696 |
| SECFB404 | 2000-03-31 | 9999-12-31 | DEBENTURES | SEC 1695/1696 |
| SECFB405 | 2000-03-31 | 9999-12-31 | OTHER (DESCRIBE BELOW) | SEC 1695/1696 |
| SECFB406 | 2000-03-31 | 9999-12-31 | BONUSES | SEC 1695/1696 |
| SECFB407 | 2000-03-31 | 9999-12-31 | VOLUNTARY CONTRIBUTIONS TO PENSION OR PROFIT SHARING PLANS | SEC 1695/1696 |
| SECFB408 | 2000-03-31 | 9999-12-31 | OTHER (DESCRIBE BELOW) | SEC 1695/1696 |
| SECFB409 | 2000-03-31 | 9999-12-31 | TOTAL | SEC 1695/1696 |
| SECFB410 | 2000-03-31 | 9999-12-31 | ADDITIONS (INCLUDES NON-CONFORMING CAPITAL OF) | SEC 1695/1696 |
| SECFB411 | 2000-03-31 | 9999-12-31 | ADDITIONS (INCLUDES NON-CONFORMING CAPITAL OF) - NET | SEC 1695/1696 |
| SECFB412 | 2000-03-31 | 9999-12-31 | DEDUCTIONS (INCLUDES NON-CONFORMING CAPITAL OF) | SEC 1695/1696 |
| SECFB413 | 2000-03-31 | 9999-12-31 | DEDUCTIONS (INCLUDES NON-CONFORMING CAPITAL OF) - NET | SEC 1695/1696 |
| SECFB414 | 2000-03-31 | 9999-12-31 | BALANCE, BEGINNING OF PERIOD | SEC 1695/1696 |
| SECFB415 | 2000-03-31 | 9999-12-31 | INCREASES | SEC 1695/1696 |
| SECFB416 | 2000-03-31 | 9999-12-31 | DECREASES | SEC 1695/1696 |
| SECFB423 | 2000-03-31 | 9999-12-31 | MONTH END TOTAL NUMBER OF STOCK RECORD BREAKS UNRESOLVED OVER THREE BUSINESS DAYS: BREAKS LONG - VALUATION | SEC 1695/1696 |
| SECFB424 | 2000-03-31 | 9999-12-31 | MONTH END TOTAL NUMBER OF STOCK RECORD BREAKS UNRESOLVED OVER THREE BUSINESS DAYS: BREAKS LONG - NUMBER | SEC 1695/1696 |
| SECFB425 | 2000-03-31 | 9999-12-31 | MONTH END TOTAL NUMBER OF STOCK RECORD BREAKS UNRESOLVED OVER THREE BUSINESS DAYS: BREAKS SHORT - VALUATION | SEC 1695/1696 |
| SECFB426 | 2000-03-31 | 9999-12-31 | MONTH END TOTAL NUMBER OF STOCK RECORD BREAKS UNRESOLVED OVER THREE BUSINESS DAYS: BREAKS SHORT - NUMBER | SEC 1695/1696 |
| SECFB427 | 2000-03-31 | 9999-12-31 | IS THE FIRM IN COMPLIANCE WITH RULE 17A-13 REGARDING PERIODIC COUNT AND VERIFICATION OF SECURITIES POSITIONS AND LOCATIONS AT LEAST ONCE IN EACH CALENDAR QUARTER? YES | SEC 1695/1696 |
| SECFB428 | 2000-03-31 | 9999-12-31 | IS THE FIRM IN COMPLIANCE WITH RULE RULE 17A-13 REGARDING PERIODIC COUNT AND VERIFICATION OF SECURITIES POSITIONS AND LOCATIONS AT LEAST ONCE IN EACH CALENDAR QUARTER? NO | SEC 1695/1696 |
| SECFB429 | 2000-03-31 | 9999-12-31 | PERSONNEL EMPLOYED AT END OF REPORTING PERIOD: INCOME PRODUCING PERSONNEL | SEC 1695/1696 |
| SECFB430 | 2000-03-31 | 9999-12-31 | PERSONNEL EMPLOYED AT END OF REPORTING PERIOD: NON-INCOME PRODUCING PERSONNEL (ALL OTHER) | SEC 1695/1696 |
| SECFB431 | 2000-03-31 | 9999-12-31 | PERSONNEL EMPLOYED AT END OF REPORTING PERIOD: TOTAL | SEC 1695/1696 |
| SECFB432 | 2000-03-31 | 9999-12-31 | ACTUAL NUMBER OF TICKETS EXECUTED DURING CURRENT MONTH OF REPORTING PERIOD | SEC 1695/1696 |
| SECFB433 | 2000-03-31 | 9999-12-31 | NUMBER OF CORRECTED CUSTOMER CONFIRMATIONS MAILED AFTER SETTLEMENT DATE | SEC 1695/1696 |
| SECFB434 | 2000-03-31 | 9999-12-31 | MONEY DIFFERENCES - NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB435 | 2000-03-31 | 9999-12-31 | MONEY DIFFERENCES - DEBIT | SEC 1695/1696 |
| SECFB436 | 2000-03-31 | 9999-12-31 | MONEY DIFFERENCES - NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB437 | 2000-03-31 | 9999-12-31 | MONEY DIFFERENCES - CREDIT | SEC 1695/1696 |
| SECFB438 | 2000-03-31 | 9999-12-31 | SECURITY SUSPENSE ACCOUNTS - NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB439 | 2000-03-31 | 9999-12-31 | SECURITY SUSPENSE ACCOUNTS - DEBIT | SEC 1695/1696 |
| SECFB440 | 2000-03-31 | 9999-12-31 | SECURITY SUSPENSE ACCOUNTS - NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB441 | 2000-03-31 | 9999-12-31 | SECURITY SUSPENSE ACCOUNTS - CREDIT | SEC 1695/1696 |
| SECFB442 | 2000-03-31 | 9999-12-31 | SECURITY DIFFERENCE ACCOUNTS - NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB443 | 2000-03-31 | 9999-12-31 | SECURITY DIFFERENCE ACCOUNTS - DEBIT | SEC 1695/1696 |
| SECFB444 | 2000-03-31 | 9999-12-31 | SECURITY DIFFERENCE ACCOUNTS - NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB445 | 2000-03-31 | 9999-12-31 | SECURITY DIFFERENCE ACCOUNTS - CREDIT | SEC 1695/1696 |
| SECFB446 | 2000-03-31 | 9999-12-31 | COMMODITY SUSPENSE ACCOUNTS - NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB447 | 2000-03-31 | 9999-12-31 | COMMODITY SUSPENSE ACCOUNTS - DEBIT | SEC 1695/1696 |
| SECFB448 | 2000-03-31 | 9999-12-31 | COMMODITY SUSPENSE ACCOUNTS- NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB449 | 2000-03-31 | 9999-12-31 | COMMODITY SUSPENSE ACCOUNTS - CREDIT | SEC 1695/1696 |
| SECFB450 | 2000-03-31 | 9999-12-31 | OPEN TRANSACTIONS WITH CORRESPONDENTS, OTHER BROKERS, CLEARING ORGANIZATIONS, DEPOSITORIES, AND INTEROFFICE AND INTERCOMPANY ACCOUTS ETC.: NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB451 | 2000-03-31 | 9999-12-31 | OPEN TRANSACTIONS WITH CORRESPONDENTS, OTHER BROKERS, CLEARING ORGANIZATIONS, DEPOSITORIES, AND INTEROFFICE AND INTERCOMPANY ACCOUTS ETC.: DEBIT | SEC 1695/1696 |
| SECFB452 | 2000-03-31 | 9999-12-31 | OPEN TRANSACTIONS WITH CORRESPONDENTS, OTHER BROKERS, CLEARING ORGANIZATIONS, DEPOSITORIES, AND INTEROFFICE AND INTERCOMPANY ACCOUTS ETC.: NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB453 | 2000-03-31 | 9999-12-31 | OPEN TRANSACTIONS WITH CORRESPONDENTS, OTHER BROKERS, CLEARING ORGANIZATIONS, DEPOSITORIES, AND INTEROFFICE AND INTERCOMPANY ACCOUTS ETC.: CREDITS | SEC 1695/1696 |
| SECFB454 | 2000-03-31 | 9999-12-31 | BANK ACCOUNT RECONCILLIATIONS - UNRESOLVED AMOUNTS OVER 30 CALENDAR DAYS, NOT CONFIRMED: NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB455 | 2000-03-31 | 9999-12-31 | BANK ACCOUNT RECONCILLIATIONS - UNRESOLVED AMOUNTS OVER 30 CALENDAR DAYS, NOT CONFIRMED: DEBIT | SEC 1695/1696 |
| SECFB456 | 2000-03-31 | 9999-12-31 | BANK ACCOUNT RECONCILLIATIONS - UNRESOLVED AMOUNTS OVER 30 CALENDAR DAYS, NOT CONFIRMED: NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB457 | 2000-03-31 | 9999-12-31 | BANK ACCOUNT RECONCILLIATIONS - UNRESOLVED AMOUNTS OVER 30 CALENDAR DAYS, NOT CONFIRMED: CREDIT | SEC 1695/1696 |
| SECFB458 | 2000-03-31 | 9999-12-31 | OPEN TRANSFERS OVER 40 CALENDAR DAYS, NOT CONFIRMED: NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB459 | 2000-03-31 | 9999-12-31 | OPEN TRANSFERS OVER 40 CALENDAR DAYS, NOT CONFIRMED: DEBIT | SEC 1695/1696 |
| SECFB460 | 2000-03-31 | 9999-12-31 | OPEN TRANSFERS OVER 40 CALENDAR DAYS, NOT CONFIRMED: NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB461 | 2000-03-31 | 9999-12-31 | OPEN TRANSFERS OVER 40 CALENDAR DAYS, NOT CONFIRMED: CREDIT | SEC 1695/1696 |
| SECFB462 | 2000-03-31 | 9999-12-31 | TRANSACTIONS IN REORGANIZATION ACCOUNTS-OVER 60 CALENDAR DAYS: NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB463 | 2000-03-31 | 9999-12-31 | TRANSACTIONS IN REORGANIZATION ACCOUNTS-OVER 60 CALENDAR DAYS: DEBIT | SEC 1695/1696 |
| SECFB464 | 2000-03-31 | 9999-12-31 | TRANSACTIONS IN REORGANIZATION ACCOUNTS-OVER 60 DAYS: NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB465 | 2000-03-31 | 9999-12-31 | TRANSACTIONS IN REORGANIZATION ACCOUNTS-OVER 60 CALENDAR DAYS: CREDIT | SEC 1695/1696 |
| SECFB466 | 2000-03-31 | 9999-12-31 | TOTAL - NO. OF DEBIT ITEMS | SEC 1695/1696 |
| SECFB467 | 2000-03-31 | 9999-12-31 | TOTAL - DEBIT | SEC 1695/1696 |
| SECFB468 | 2000-03-31 | 9999-12-31 | TOTAL - NO. OF CREDIT ITEMS | SEC 1695/1696 |
| SECFB469 | 2000-03-31 | 9999-12-31 | TOTAL - CREDIT | SEC 1695/1696 |
| SECFB470 | 2000-03-31 | 9999-12-31 | FAILED TO DELIVER 11 BUSINESS DAYS OR LONGER (21 BUSINESS DAYS OR LONGER IN THE CASE OF MUNICIPAL SECURITIES): NO. OF ITEMS | SEC 1695/1696 |
| SECFB471 | 2000-03-31 | 9999-12-31 | FAILED TO DELIVER 11 BUSINESS DAYS OR LONGER (21 BUSINESS DAYS OR LONGER IN THE CASE OF MUNICIPAL SECURITIES): LEGER AMOUNT | SEC 1695/1696 |
| SECFB472 | 2000-03-31 | 9999-12-31 | FAILED TO DELIVER 11 BUSINESS DAYS OR LONGER (21 BUSINESS DAYS OR LONGER IN THE CASE OF MUNICIPAL SECURITIES: MARKET VALUE | SEC 1695/1696 |
| SECFB473 | 2000-03-31 | 9999-12-31 | FAILED TO RECEIVE 11 BUSINESS DAYS OR LONGER (21 BUSINESS DAYS OR LONGER IN THE CASE OF MUNICIPAL SECURITIES): NO. OF ITEMS | SEC 1695/1696 |
| SECFB474 | 2000-03-31 | 9999-12-31 | FAILED TO RECEIVE 11 BUSINESS DAYS OR LONGER (21 BUSINESS DAYS OR LONGER IN THE CASE OF MUNICIPAL SECURITIES): LEGER AMOUNT | SEC 1695/1696 |
| SECFB475 | 2000-03-31 | 9999-12-31 | FAILED TO RECEIVE 11 BUSINES DAYS OR LONGER (21 BUSINESS DAY OR LONGER IN THE CASE OF MUNICIPAL SECURITIES): MARKET VALUE | SEC 1695/1696 |
| SECFB476 | 2000-03-31 | 9999-12-31 | SECURITY CONCENTRATIONS: PROPRIETARY POSITIONS | SEC 1695/1696 |
| SECFB477 | 2000-03-31 | 9999-12-31 | SECURITY CONCENTRATIONS: CUSTOMERS' ACCOUNTS UNDER RULE 15C3-3 | SEC 1695/1696 |
| SECFB478 | 2000-03-31 | 9999-12-31 | TOTAL OF PERSONAL CAPITAL BORROWINGS DUE WITHIN SIX MONTHS | SEC 1695/1696 |
| SECFB479 | 2000-03-31 | 9999-12-31 | MAXIMUM HAIRCUTS ON UNDERWRITING COMMITMENTS DURING THE PERIOD | SEC 1695/1696 |
| SECFB480 | 2000-03-31 | 9999-12-31 | PLANNED CAPITAL EXPENDITURES FOR BUSINESS EXPANSION DURING NEXT SIX MONTHS | SEC 1695/1696 |
| SECFB481 | 2000-03-31 | 9999-12-31 | LIABILITIES OF OTHER INDIVIDUALS OR ORGANIZATIONS GUARANTEED BY RESPONDENT | SEC 1695/1696 |
| SECFB482 | 2000-03-31 | 9999-12-31 | LEASE AND RENTALS PAYABLE WITHIN ONE YEAR | SEC 1695/1696 |
| SECFB483 | 2000-03-31 | 9999-12-31 | AGGREGATE LEASE AND RENTAL COMMITMENTS PAYABLE FOR ENTIRE TERM OF THE LEASE: GROSS | SEC 1695/1696 |
| SECFB484 | 2000-03-31 | 9999-12-31 | AGGREGATE LEASE AND RENTAL COMMITMENTS PAYABLE FOR ENTIRE TERM OF THE LEASE: NET | SEC 1695/1696 |
| SECFB829 | 2000-03-31 | 9999-12-31 | SECURITIES OWNED NOT READILY MARKETABLE: AT ESTIMATED FAIR VALUE | SEC 1695/1696 |
| SECFB830 | 2000-03-31 | 9999-12-31 | SECURITIES BORROWED UNDER SUBORDINATION AGREEMENTS AND PARTNERS' INDIVIDUAL AND CAPITAL SECURITIES ACCOUNTS, AT MARKET VALUE: OTHER | SEC 1695/1696 |
| SECFB831 | 2000-03-31 | 9999-12-31 | SECURED DEMAND NOTES MARKET VALUE OF COLLATERAL: OTHER | SEC 1695/1696 |
| SECFB832 | 2000-03-31 | 9999-12-31 | PAYABLE TO CUSTOMERS: SECURITIES ACCOUNTS-INCLUDING FREE CREDITS OF | SEC 1695/1696 |
| SECFB833 | 2000-03-31 | 9999-12-31 | SECURITIES SOLD NOT YET PURCHASED AT MARKET VALUE-INCLUDING ARBITRAGE OF | SEC 1695/1696 |
| SECFB862 | 2000-03-31 | 9999-12-31 | OTHER EMPLOYEE COMPENSATION AND BENEFITS | SEC 1695/1696 |
| SECFB863 | 2000-03-31 | 9999-12-31 | COMMISSIONS PAID TO OTHER BROKER-DEALERS | SEC 1695/1696 |
| SECFB864 | 2000-03-31 | 9999-12-31 | IS RESPONDENT FILING AN AUDITED FOCUS REPORT? | SEC 1695/1696 |
| SECFB865 | 2000-03-31 | 9999-12-31 | AGENCY (DEA) CODE | SEC 1695/1696 |
| SECFB866 | 2000-03-31 | 9999-12-31 | SEC FILING RULE | SEC 1695/1696 |
| SECFC034 | 2000-03-31 | 9999-12-31 | FIRM ID NUMBER OR SELF-REGULATORY ORGANIZATION ID | SEC 1695/1696 |
| SECFC368 | 2021-10-06 | 9999-12-31 | PRIMARY CONTACT - E-MAIL ADDRESS | SEC 1695/1696 |
| SECFC454 | 2002-03-31 | 9999-12-31 | TOTAL INVENTORY | SEC 1695/1696 |
| SECFC457 | 2002-03-31 | 9999-12-31 | OBLIGATION TO RETURN SECURITIES | SEC 1695/1696 |
| SECFC458 | 2002-03-31 | 9999-12-31 | SPE LIABILITIES | SEC 1695/1696 |
| SECFF030 | 2021-10-06 | 9999-12-31 | PRINTED NAME OF CHIEF FINANCIAL OFFICER | SEC 1695/1696 |
| SECFF317 | 2006-09-30 | 9999-12-31 | DERIVATIVE RECEIVABLES | SEC 1695/1696 |
| SECFF318 | 2006-09-30 | 9999-12-31 | TRADE DATE RECEIVABLE | SEC 1695/1696 |
| SECFF320 | 2006-09-30 | 9999-12-31 | TOTAL DERIVATIVE PAYABLES | SEC 1695/1696 |
| SECFF321 | 2006-09-30 | 9999-12-31 | TOTAL TRADE DATE PAYABLE | SEC 1695/1696 |
| SECFF322 | 2006-09-30 | 9999-12-31 | TOTAL MARKET RISK EXPOSURE | SEC 1695/1696 |
| SECFF323 | 2006-09-30 | 9999-12-31 | TOTAL CREDIT RISK EXPOSURE | SEC 1695/1696 |
| SECFF324 | 2006-09-30 | 9999-12-31 | COMMISSIONS ON COMMODITY TRANSACTIONS | SEC 1695/1696 |
| SECFF325 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON DERIVATIVE TRADING DESKS; INTEREST RATE/FIXED INCOME PRODUCTS | SEC 1695/1696 |
| SECFF326 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON DERIVATIVE TRADING DESKS; CURRENCY | SEC 1695/1696 |
| SECFF327 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON DERIVATIVE TRADING DESKS; EQUITY PRODUCTS | SEC 1695/1696 |
| SECFF328 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON DERIVATIVE TRADING DESKS; COMMODITY PRODUCTS | SEC 1695/1696 |
| SECFF329 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON DERIVATIVE TRADING DESKS; OTHER | SEC 1695/1696 |
| SECFF330 | 2006-09-30 | 9999-12-31 | TOTAL GAINS OR LOSSES ON DERIVATIVE TRADING DESKS | SEC 1695/1696 |
| SECFF331 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS WITH ASSOCIATED HEDGES; INTEREST RATE/FIXED INCOME | SEC 1695/1696 |
| SECFF332 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS WITH ASSOCIATED HEDGES; CURRENCY | SEC 1695/1696 |
| SECFF333 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS WITH ASSOCIATED HEDGES; EQUITY | SEC 1695/1696 |
| SECFF334 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS WITH ASSOCIATED HEDGES; COMMODITY | SEC 1695/1696 |
| SECFF335 | 2006-09-30 | 9999-12-31 | GAINS OR LOSSES ON FIRM SECURITIES TRADING ACCOUNTS WITH ASSOCIATED HEDGES; OTHER | SEC 1695/1696 |
| SECFF336 | 2006-09-30 | 9999-12-31 | OTHER INTEREST | SEC 1695/1696 |
| SECFF347 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: U.S. TREASURY SECURITIES | SEC 1695/1696 |
| SECFF348 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: U.S. GOVERNMENT AGENCY AND GOVERNMENT SPONSORED ENTITIES | SEC 1695/1696 |
| SECFF349 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: SECURITIES ISSUED BY STATES AND POLITICAL SUBDIVISIONS IN THE U.S. | SEC 1695/1696 |
| SECFF350 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: FOREIGN SECURITIES: DEBT SECURITIES | SEC 1695/1696 |
| SECFF351 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: FOREIGN SECURITIES: EQUITY SECURITIES | SEC 1695/1696 |
| SECFF352 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: MONEY MARKET INSTRUMENTS | SEC 1695/1696 |
| SECFF353 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: PRIVATE LABEL MORTGAGE BACKED SECURITIES | SEC 1695/1696 |
| SECFF354 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: OTHER ASSET BACK SECURITIES | SEC 1695/1696 |
| SECFF355 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: CORPORATE OBLIGATIONS | SEC 1695/1696 |
| SECFF356 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: STOCKS AND WARRENTS (OTHER THAN ARBITRAGE POSITIONS) | SEC 1695/1696 |
| SECFF357 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: ARBITRAGE | SEC 1695/1696 |
| SECFF358 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: DERIVATIVES INCLUDING OPTIONS | SEC 1695/1696 |
| SECFF359 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: SPOT COMMODITIES | SEC 1695/1696 |
| SECFF360 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: INVESTMENTS WITH NO READY MARKET EQUITY | SEC 1695/1696 |
| SECFF361 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: INVESTMENTS WITH NO READY MARKET DEBT | SEC 1695/1696 |
| SECFF362 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: INVESTMENTS WITH NO READY MARKET OTHER (INCLUDE LIMITED PARTNERSHIP INTERESTS) | SEC 1695/1696 |
| SECFF363 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: OTHER SECURITIES OR COMMODITIES | SEC 1695/1696 |
| SECFF364 | 2006-09-30 | 9999-12-31 | AGGREGATE SECURITIES AND COMMODITIES POSITIONS: TOTAL | SEC 1695/1696 |
| SECFF365 | 2006-09-30 | 9999-12-31 | FREE CREDIT BALANCES AND OTHER CREDIT BALANCES IN PROPRIETARY ACCOUNTS OF INTRODUCING BROKERS (PAIB) | SEC 1695/1696 |
| SECFF366 | 2007-09-30 | 9999-12-31 | MONIES BORROWED COLLATERALIZED BY SECURITIES CARRIED FOR PAIB | SEC 1695/1696 |
| SECFF367 | 2006-09-30 | 9999-12-31 | MONIES PAYABLE AGAINST PAIB SECURITIES LOANED (SEE NOTE 2-PAIB) | SEC 1695/1696 |
| SECFF368 | 2006-09-30 | 9999-12-31 | PAIB SECURITIES FAILED TO RECEIVE | SEC 1695/1696 |
| SECFF369 | 2006-09-30 | 9999-12-31 | CREDIT BALANCES IN FIRM ACCOUNTS WHICH ARE ATTRIBUTABLE TO PRINCIPAL SALES TO PAIB | SEC 1695/1696 |
| SECFF370 | 2006-09-30 | 9999-12-31 | CREDIT BALANCES -- OTHER | SEC 1695/1696 |
| SECFF371 | 2006-09-30 | 9999-12-31 | TOTAL PAIB CREDITS | SEC 1695/1696 |
| SECFF372 | 2006-09-30 | 9999-12-31 | DEBIT BALANCES IN PAIB EXCLUDING UNSECURED ACCOUNTS AND ACCOUNTS DOUBTFUL OF COLLECTION | SEC 1695/1696 |
| SECFF373 | 2006-09-30 | 9999-12-31 | SECURITIES BORROWED TO EFFECTUATE SHORT SALES BY PAIB AND SECURITIES BORROWED TO MAKE DELIVERY ON PAIB SECURITIES FAILED TO DELIVER | SEC 1695/1696 |
| SECFF374 | 2006-09-30 | 9999-12-31 | FAILED TO DELIVER OF PAIB SECURITIES NOT OLDER THAN 30 CALENDAR DAYS | SEC 1695/1696 |
| SECFF375 | 2006-09-30 | 9999-12-31 | MARGIN REQUIRED AND ON DEPOSIT WITH OPTIONS CLEARING CORPORATION FOR ALL OPTION CONTRACTS WRITTEN OR PURCHASED IN PAIB ACCOUNTS | SEC 1695/1696 |
| SECFF376 | 2006-09-30 | 9999-12-31 | MARGIN RELATED TO SECURITY FUTURES PRODUCTS WRITTEN PURCHASED OR SOLD IN PAIB ACCOUNTS REQUIRED AND ON DEPOSIT WITH A CLEARING AGENCY OR A DERIVATIVE CLEARING ORGANIZATION. | SEC 1695/1696 |
| SECFF377 | 2006-09-30 | 9999-12-31 | DEBIT BALANCES -- OTHER | SEC 1695/1696 |
| SECFF378 | 2006-09-30 | 9999-12-31 | TOTAL PAIB DEBITS | SEC 1695/1696 |
| SECFF379 | 2006-09-30 | 9999-12-31 | RESERVE COMPUTATION: EXCESS OF TOTAL PAIB DEBITS OVER TOTAL PAIB CREDITS | SEC 1695/1696 |
| SECFF380 | 2006-09-30 | 9999-12-31 | RESERVE COMPUTATION: EXCESS OF TOTAL PAIB CREDITS OVER TOTAL PAIB DEBITS | SEC 1695/1696 |
| SECFF381 | 2006-09-30 | 9999-12-31 | EXCESS DEBITS IN CUSTOMER RESERVE FORMULA COMPUTATION | SEC 1695/1696 |
| SECFF382 | 2006-09-30 | 9999-12-31 | PAIB RESERVE REQUIREMENT | SEC 1695/1696 |
| SECFF383 | 2006-09-30 | 9999-12-31 | AMOUNT HELD ON DEPOSIT IN "RESERVE BANK ACCOUNT(S)," INCLUDING | SEC 1695/1696 |
| SECFF384 | 2006-09-30 | 9999-12-31 | AMOUNT HELD ON DEPOSIT IN "RESERVE BANK ACCOUNT(S)," INCLUDING VALUE OF QUALIFIED SECURITIES, AT END OF REPORTING PERIOD | SEC 1695/1696 |
| SECFF385 | 2006-09-30 | 9999-12-31 | AMOUNT OF DEPOSIT (OR WITHDRAWAL) INCLUDING | SEC 1695/1696 |
| SECFF386 | 2006-09-30 | 9999-12-31 | AMOUNT OF DEPOSIT (OR WITHDRAWAL) INCLUDING VALUE OF QUALIFIED SECURITIES | SEC 1695/1696 |
| SECFF387 | 2006-09-30 | 9999-12-31 | NEW AMOUNT IN RESERVE BANK ACCOUNT(S) AFTER ADDING DEPOSIT OR SUBTRACTING | SEC 1695/1696 |
| SECFF388 | 2006-09-30 | 9999-12-31 | NEW AMOUNT IN RESERVE BANK ACCOUNT(S) AFTER ADDING DEPOSIT OR SUBTRACTING VALUE OF QUALIFIED SECURITIES | SEC 1695/1696 |
| SECFF389 | 2006-09-30 | 9999-12-31 | DATE OF DEPOSIT (MMDDYY) | SEC 1695/1696 |
| SECFF390 | 2006-09-30 | 9999-12-31 | FREQUENCY OF COMPUTATION: DAILY | SEC 1695/1696 |
| SECFF391 | 2006-09-30 | 9999-12-31 | FREQUENCY OF COMPUTATION: WEEKLY | SEC 1695/1696 |
| SECFF392 | 2006-09-30 | 9999-12-31 | FREQUENCY OF COMPUTATION: MONTHLY | SEC 1695/1696 |
| SECFF393 | 2006-09-30 | 9999-12-31 | ACCOUNTS LIQUIDATING TO A DEFICIT AND ACCOUNTS WITH DEBIT BALANCES -- GROSS AMOUNT | SEC 1695/1696 |
| SECFF394 | 2006-09-30 | 9999-12-31 | ACCOUNTS LIQUIDATING TO A DEFICIT AND ACCOUNTS WITH DEBIT BALANCES -- LESS: AMOUNT OFFSET BY CUSTOMER OWNED SECURITIES | SEC 1695/1696 |
| SECFF395 | 2006-09-30 | 9999-12-31 | AMOUNT REQUIRED TO BE SEGREGATED IN ACCORDANCE WITH COMMISSION REGULATION 32.6 | SEC 1695/1696 |
| SECFF396 | 2006-09-30 | 9999-12-31 | CASH IN SEGREGATED ACCOUNTS | SEC 1695/1696 |
| SECFF397 | 2006-09-30 | 9999-12-31 | SECURITIES (AT MARKET) IN SEGREGATED ACCOUNTS | SEC 1695/1696 |
| SECFF398 | 2006-09-30 | 9999-12-31 | TOTAL FUNDS IN SEGREGATED ACCOUNTS | SEC 1695/1696 |
| SECFF399 | 2006-09-30 | 9999-12-31 | EXCESS (DEFICIENCY) FUNDS IN SEGREGATION | SEC 1695/1696 |
| SECFF400 | 2006-09-30 | 9999-12-31 | AMOUNT TO BE SET ASIDE IN SEPARATE SECTION -- 30.7 ACCOUNTS | SEC 1695/1696 |
| SECFF401 | 2006-09-30 | 9999-12-31 | TOTAL FUNDS IN SEPARATE SECTION 30.7 ACCOUNTS | SEC 1695/1696 |
| SECFF402 | 2006-09-30 | 9999-12-31 | EXCESS (DEFICIENCY) | SEC 1695/1696 |
| SECFF403 | 2006-09-30 | 9999-12-31 | FUNDS DEPOSITED IN SEPARATE REGULATION 30.7 ACCOUNTS: CASH IN BANKS, BANKS LOCATED IN THE UNITED STATES. | SEC 1695/1696 |
| SECFF404 | 2006-09-30 | 9999-12-31 | FUNDS DEPOSITED IN SEPARATE REGULATION 30.7 ACCOUNTS; CASH IN BANKS, OTHER BANKS DESIGNATED BY THE COMMISSION | SEC 1695/1696 |
| SECFF405 | 2006-09-30 | 9999-12-31 | SECURITIES: IN SAFEKEEPING WITH BANKS LOCATED IN THE UNITED STATES | SEC 1695/1696 |
| SECFF406 | 2006-09-30 | 9999-12-31 | SECURITIES: IN SAFEKEEPING WITH OTHER BANKS DESIGNATED BY THE COMMISSION | SEC 1695/1696 |
| SECFF407 | 2006-09-30 | 9999-12-31 | EQUITIES WITH REGISTERED FUTURES COMMISSION MERCHANTS: CASH | SEC 1695/1696 |
| SECFF408 | 2006-09-30 | 9999-12-31 | EQUITIES WITH REGISTERED FUTURES COMMISSION MERCHANTS: SECURITIES | SEC 1695/1696 |
| SECFF409 | 2006-09-30 | 9999-12-31 | EQUITIES WITH REGISTERED FUTURES COMMISSION MERCHANTS: UNREALIZED GAIN (LOSS) ON OPEN FUTURES CONTRACTS | SEC 1695/1696 |
| SECFF410 | 2006-09-30 | 9999-12-31 | EQUITIES WITH REGISTERED FUTURES COMMISSION MERCHANTS: VALUE OF LONG OPTION CONTRACTS | SEC 1695/1696 |
| SECFF411 | 2006-09-30 | 9999-12-31 | EQUITIES WITH REGISTERED FUTURES COMMISSION MERCHANTS: VALUE OF SHORT OPTION CONTRACTS | SEC 1695/1696 |
| SECFF412 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY CLEARING ORGANIZATIONS OF FOREIGN BOARDS OF TRADE: NAME | SEC 1695/1696 |
| SECFF413 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY CLEARING ORGANIZATIONS OF FOREIGN BOARDS OF TRADE: CASH | SEC 1695/1696 |
| SECFF414 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY CLEARING ORGANIZATIONS OF FOREIGN BOARDS OF TRADE: SECURITIES | SEC 1695/1696 |
| SECFF415 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY CLEARING ORGANIZATIONS OF FOREIGN BOARDS OF TRADE: AMOUNT DUE TO(FROM) CLEARING ORGANIZATIONS - DAILY VARIATION | SEC 1695/1696 |
| SECFF416 | 2006-09-30 | 9999-12-31 | FOREIGN FUTURES AND FOREIGN OPTIONS SECURED AMOUNTS: SECURED AMOUNTS IN ONLY U.S. - DOMICILED CUSTOMERS' ACCOUNTS | SEC 1695/1696 |
| SECFF417 | 2006-09-30 | 9999-12-31 | FOREIGN FUTURES AND FOREIGN OPTIONS SECURED AMOUNTS: SECURED AMOUNTS IN U.S. AND FOREIGN - DOMICILED CUSTOMERS' ACCOUNTS | SEC 1695/1696 |
| SECFF418 | 2006-09-30 | 9999-12-31 | FOREIGN FUTURES AND FOREIGN OPTIONS SECURED AMOUNTS - SUMMARY: NET LIQUIDATING EQUITIES IN ALL ACCOUNTS OF CUSTOMERS. | SEC 1695/1696 |
| SECFF419 | 2006-09-30 | 9999-12-31 | FOREIGN FUTURES AND FOREIGN OPTIONS SECURED AMOUNTS - SUMMARY: AMOUNT REQUIRED TO BE SET ASIDE PURSUANT TO LAW, RULE OR REGULATION OF A FOREIGN GOVERNMENT OR A RULE OF A SELF-REGULATORY ORGANIZATION AUTHORIZED THEREUNDER. | SEC 1695/1696 |
| SECFF420 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY CLEARING ORGANIZATIONS OF FOREIGN BOARDS OF TRADE: VALUE OF LONG OPTION CONTRACTS | SEC 1695/1696 |
| SECFF421 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY CLEARING ORGANIZATIONS OF FOREIGN BOARDS OF TRADE: VALUE OF SHORT OPTION CONTRACTS | SEC 1695/1696 |
| SECFF422 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY MEMBERS OF FOREIGN BOARDS OF TRADE: NAME(S) | SEC 1695/1696 |
| SECFF423 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY MEMBERS OF FOREIGN BOARDS OF TRADE: CASH | SEC 1695/1696 |
| SECFF424 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY MEMBERS OF FOREIGN BOARDS OF TRADE: SECURITIES | SEC 1695/1696 |
| SECFF425 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY MEMBERS OF FOREIGN BOARDS OF TRADE: UNREALIZED GAIN (LOSS) ON OPEN FUTURES CONTRACTS | SEC 1695/1696 |
| SECFF426 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY MEMBERS OF FOREIGN BOARDS OF TRADE: VALUE OF LONG OPTION CONTRACTS | SEC 1695/1696 |
| SECFF427 | 2006-09-30 | 9999-12-31 | AMOUNTS HELD BY MEMBERS OF FOREIGN BOARDS OF TRADE: VALUE OF SHORT OPTION CONTRACTS | SEC 1695/1696 |
| SECFF428 | 2006-09-30 | 9999-12-31 | AMOUNTS WITH OTHER DEPOSITORIES DESIGNATED BY A FOREIGN BOARD OF TRADE: NAME(S) | SEC 1695/1696 |
| SECFF429 | 2006-09-30 | 9999-12-31 | SEGREGATED FUNDS ON HAND | SEC 1695/1696 |
| SECFF430 | 2006-09-30 | 9999-12-31 | RISK-BASED REQUIREMENT: AMOUNT OF CUSTOMER RISK MAINTENANCE MARGIN REQUIREMENT | SEC 1695/1696 |
| SECFF431 | 2006-09-30 | 9999-12-31 | RISK-BASED REQUIREMENT: ENTER 8 PERCENT OF LINE A.I | SEC 1695/1696 |
| SECFF432 | 2006-09-30 | 9999-12-31 | RISK-BASED REQUIREMENT: AMOUNT OF NON-CUSTOMER RISK MAINTENANCE MARGIN REQUIREMENT | SEC 1695/1696 |
| SECFF433 | 2006-09-30 | 9999-12-31 | NET CAPITAL REQUIRED RISK-BASED REQUIREMENT: ENTER 4 PERCENT OF LINE A.III | SEC 1695/1696 |
| SECFF434 | 2006-09-30 | 9999-12-31 | NET CAPITAL REQUIRED RISK-BASED REQUIREMENT: ADD LINES A.II AND A.IV | SEC 1695/1696 |
| SECFF435 | 2006-09-30 | 9999-12-31 | NET CAPITAL REQUIREMENT: MINIMUM DOLLAR AMOUNT REQUIREMENT | SEC 1695/1696 |
| SECFF436 | 2006-09-30 | 9999-12-31 | NET CAPITAL REQUIRED OTHER NFA REQUIREMENT | SEC 1695/1696 |
| SECFF437 | 2006-09-30 | 9999-12-31 | NET CAPITAL REQUIRED: MINIMUM CFTC NET CAPITAL REQUIREMENT | SEC 1695/1696 |
| SECFF438 | 2006-09-30 | 9999-12-31 | CFTC EARLY WARNING LEVEL | SEC 1695/1696 |
| SECFF439 | 2006-09-30 | 9999-12-31 | MARKET RISK EXPOSURE: TOTAL VALUE AT RISK | SEC 1695/1696 |
| SECFF440 | 2006-09-30 | 9999-12-31 | VALUE AT RISK COMPONENTS: FIXED INCOME VAR | SEC 1695/1696 |
| SECFF441 | 2006-09-30 | 9999-12-31 | VALUE AT RISK COMPONENTS: CURRENCY VAR | SEC 1695/1696 |
| SECFF442 | 2006-09-30 | 9999-12-31 | VALUE AT RISK COMPONENTS: COMMODITIES VAR | SEC 1695/1696 |
| SECFF443 | 2006-09-30 | 9999-12-31 | VALUE AT RISK COMPONENTS: EQUITIES VAR | SEC 1695/1696 |
| SECFF444 | 2006-09-30 | 9999-12-31 | VALUE AT RISK COMPONENTS: CREDIT DERIVATIVES VAR | SEC 1695/1696 |
| SECFF445 | 2006-09-30 | 9999-12-31 | MARKET RISK EXPOSURE: DIVERSIFICATION BENEFIT | SEC 1695/1696 |
| SECFF446 | 2006-09-30 | 9999-12-31 | MARKET RISK EXPOSURE: TOTAL DIVERSIFIED VAR | SEC 1695/1696 |
| SECFF447 | 2006-09-30 | 9999-12-31 | MARKET RISK EXPOSURE: MULTIPLICATION FACTOR | SEC 1695/1696 |
| SECFF448 | 2006-09-30 | 9999-12-31 | MARKET RISK EXPOSURE: SUBTOTAL | SEC 1695/1696 |
| SECFF449 | 2006-09-30 | 9999-12-31 | DEDUCTION FOR SPECIFIC RISK, UNLESS INCLUDED IN 1 ABOVE | SEC 1695/1696 |
| SECFF450 | 2006-09-30 | 9999-12-31 | RISK DEDUCTION USING SCENARIO ANALYSIS | SEC 1695/1696 |
| SECFF451 | 2006-09-30 | 9999-12-31 | RISK DEDUCTION USING SCENARIO ANALYSIS: FIXED INCOME | SEC 1695/1696 |
| SECFF452 | 2006-09-30 | 9999-12-31 | RISK DEDUCTION USING SCENARIO ANALYSIS: CURRENCY | SEC 1695/1696 |
| SECFF453 | 2006-09-30 | 9999-12-31 | RISK DEDUCTION USING SCENARIO ANALYSIS: COMMODITIES | SEC 1695/1696 |
| SECFF454 | 2006-09-30 | 9999-12-31 | RISK DEDUCTION USING SCENARIO ANALYSIS: EQUITIES | SEC 1695/1696 |
| SECFF455 | 2006-09-30 | 9999-12-31 | RISK DEDUCTION USING SCENARIO ANALYSIS: CREDIT DERIVATIVES | SEC 1695/1696 |
| SECFF456 | 2006-09-30 | 9999-12-31 | RESIDUAL MARKETABLE SECURITIES | SEC 1695/1696 |
| SECFF457 | 2006-09-30 | 9999-12-31 | TOTAL MARKET RISK EXPOSURE | SEC 1695/1696 |
| SECFF458 | 2006-09-30 | 9999-12-31 | CREDIT RISK EXPOSURE: CREDIT RISK CHARGE (COUNTER PARTY) | SEC 1695/1696 |
| SECFF459 | 2006-09-30 | 9999-12-31 | CREDIT RISK EXPOSURE: COUNTER PARTY CONCENTRATION CHARGE | SEC 1695/1696 |
| SECFF460 | 2006-09-30 | 9999-12-31 | CREDIT RISK EXPOSURE: COUNTER PARTY CONCENTRATION CHARGE CREDIT RISK WEIGHT LESS THAN 20 PERCENT | SEC 1695/1696 |
| SECFF461 | 2006-09-30 | 9999-12-31 | CREDIT RISK EXPOSURE: COUNTER PARTY CONCENTRATION CHARGE CREDIT RISK WEIGHT GREATER THAN 20 AND LESS THAN 50 PERCENT | SEC 1695/1696 |
| SECFF462 | 2006-09-30 | 9999-12-31 | CREDIT RISK EXPOSURE: COUNTER PARTY CONCENTRATION CHARGE CREDIT RISK WEIGHT GREATER THAN 50 PERCENT | SEC 1695/1696 |
| SECFF463 | 2006-09-30 | 9999-12-31 | CREDIT RISK EXPOSURE: PORTFOLIO CONCENTRATION CHARGE | SEC 1695/1696 |
| SECFF464 | 2006-09-30 | 9999-12-31 | TOTAL CREDIT RISK EXPOSURE (ADD LINES 6A, 6B AND 6C) | SEC 1695/1696 |
| SECFF466 | 2006-09-30 | 9999-12-31 | HAS THE FMC CHANGED THE METHOD OF CALCULATING THE AMOUNT TO BE SET ASIDE IN SEPARATE ACCOUNTS SINCE THE LAST FINANCIAL REPORT IT FILED? YES | SEC 1695/1696 |
| SECFF467 | 2006-09-30 | 9999-12-31 | HAS THE FMC CHANGED THE METHOD OF CALCULATING THE AMOUNT TO BE SET ASIDE IN SEPARATE ACCOUNTS SINCE THE LAST FINANCIAL REPORT IT FILED? NO | SEC 1695/1696 |
| SECFFT42 | 2021-10-06 | 9999-12-31 | CHIEF EXECUTIVE OFFICER NAME | SEC 1695/1696 |
| SECFNL83 | 2021-10-06 | 9999-12-31 | This report is being filed by a/an: Broker-dealer not registered as an SBSD or MSBSP (stand-alone broker-dealer ) | SEC 1695/1696 |
| SECFNL84 | 2021-10-06 | 9999-12-31 | This report is being filed by a/an: Broker-dealer registered as an SBSD (broker-dealer SBSD) | SEC 1695/1696 |
| SECFNL85 | 2021-10-06 | 9999-12-31 | This report is being filed by a/an: Broker-dealer registered as an MSBSP (broker-dealer MSBSP) | SEC 1695/1696 |
| SECFNL86 | 2021-10-06 | 9999-12-31 | This report is being filed by a/an: SBSD without a prudential regulator and not registered as a broker-dealer (stand-alone SBSD) | SEC 1695/1696 |
| SECFNL87 | 2021-10-06 | 9999-12-31 | This report is being filed by a/an: MSBSP without a prudential regulator and not registered as a broker-dealer (stand-alone MSBSP) | SEC 1695/1696 |
| SECFNL88 | 2021-10-06 | 9999-12-31 | This report is being filed by a/an: Check here if respondent is an OTC derivatives dealer | SEC 1695/1696 |
| SECFNL89 | 2021-10-06 | 9999-12-31 | This report is being filed by a: Firm authorized to use models | SEC 1695/1696 |
| SECFNL90 | 2021-10-06 | 9999-12-31 | This report is being filed by a: U.S. person | SEC 1695/1696 |
| SECFNL91 | 2021-10-06 | 9999-12-31 | This report is being filed by a: Non- U.S. person | SEC 1695/1696 |
| SECFNL92 | 2021-10-06 | 9999-12-31 | This report is being filed pursuant to: Rule 18a-7 | SEC 1695/1696 |
| SECFNL93 | 2021-10-06 | 9999-12-31 | Name of: Principal Operations Officer or Comparable Officer | SEC 1695/1696 |
| SECFNL94 | 2021-10-06 | 9999-12-31 | Assets: Excess cash collateral pledged on derivative transactions | SEC 1695/1696 |
| SECFNL95 | 2021-10-06 | 9999-12-31 | Assets: Total net securities, commodities, and swaps positions | SEC 1695/1696 |
| SECFNL96 | 2021-10-06 | 9999-12-31 | Liabilities: Excess cash collateral received on derivative transactions | SEC 1695/1696 |
| SECFNL97 | 2021-10-06 | 9999-12-31 | Liabilities: Total net securities, commodities, and swaps positions | SEC 1695/1696 |
| SECFNL98 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Deductions and/or charges: Total nonallowable assets from Statement of Financial Condition: Additional charges for customers' and non-customers' security-based swap accounts (Filer authorized to use models) | SEC 1695/1696 |
| SECFNL99 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Deductions and/or charges: Total nonallowable assets from Statement of Financial Condition: Additional charges for customers' and non-customers' swap accounts (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM00 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM01 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total value at risk (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM02 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total value at risk: Value at risk components: Fixed income VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM03 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total value at risk: Value at risk components: Currency VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM04 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total value at risk: Value at risk components: Commodities VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM05 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total value at risk: Value at risk components: Equities VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM06 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total value at risk: Value at risk components: Credit derivatives VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM07 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Diversification benefit (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM08 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total diversified VaR (sum of Line 10A and 10B) (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM09 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Multiplication factor to find product of subtotal of total diversified VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM10 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Subtotal (Line 10C is multiplied by Line 10D) of total diversified VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM11 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Total stressed VaR (SVaR) (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM12 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Multiplication factor to find product of subtotal of total stressed VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM13 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Subtotal (Line 10F multiplied by Line 10G) of total stressed VaR (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM14 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Incremental risk charge (IRC) (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM15 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Comprehensive risk measure (CRM) (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM16 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Specific risk - standard specific market risk (SSMR) (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM17 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Specific risk - securitization (SFA / SSFA) (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM18 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Alternative method for equities under Appendix A to Rule 15c3-1 or Rule 18a-1a, as applicable (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM19 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Residual positions (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM20 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Market risk exposure - for Basel 2.5 firms: Other (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM21 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Credit risk exosure for certain counterparties: Counterparty exposure charge: Net replacement value default, bankruptcy (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM22 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Credit risk exposure for certain counterparties: Counterparty exposure charge: Credit equivalent amount exposure to the counterparty multiplied by the credit-risk weight of the counterparty multiplied by 8% (Filer authorized to use models) | SEC 1695/1696 |
| SECFNM23 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Deductions and/or charges: Total nonallowable assets from Statement of Financial Condition: Additional charges for customers' and non-customers' security-based swap accounts (Filer not authorized to use models) | SEC 1695/1696 |
| SECFNM24 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Deductions and/or charges: Total nonallowable assets from Statement of Financial Condition: Additional charges for customers' and non-customers' swap accounts (Filer not authorized to use models) | SEC 1695/1696 |
| SECFNM25 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Haircuts on securities other than security-based swaps: Risk-based haircuts computed under 17 CFR 240.15c3-1a or 17 CFR 240.18a-1a (Filer not authorized to use models) | SEC 1695/1696 |
| SECFNM26 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Haircuts on security-based swaps (Filer not authorized to use models) | SEC 1695/1696 |
| SECFNM27 | 2021-10-06 | 9999-12-31 | Computation of Net Capital: Haircuts on swaps (Filer not authorized to use models) | SEC 1695/1696 |
| SECFNM28 | 2021-10-06 | 9999-12-31 | Calculation of Excess Tentative Net Capital (If Applicable): Minimum tentative net capital requirement (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM29 | 2021-10-06 | 9999-12-31 | Calculation of Excess Tentative Net Capital (If Applicable): Excess tentative net capital (difference between Lines 1 and 2) (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM30 | 2021-10-06 | 9999-12-31 | Calculation of Excess Tentative Net Capital (If Applicable): Tentative net capital in excess of 120% of minimum tentative net capital requirement reported on Line 2 (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM31 | 2021-10-06 | 9999-12-31 | Calculation of Minimum Net Capital Requirement: Ratio minimum net capital requirement: Percentage of risk margin amount computed under 17 CFR 240.15c3-1(a)(7)(i) or (a)(10) (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM32 | 2021-10-06 | 9999-12-31 | Calculation of Minimum Net Capital Requirement: Ratio minimum net capital requirement: For broker-dealers engaged in reverse repurchase agreements, 10% of the amounts in 17 CFR 240.15c3-1(a)(9)(i)-(iii) (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM33 | 2021-10-06 | 9999-12-31 | Calculation of Minimum Net Capital Requirement: Ratio minimum net capital requirement: Minimum ratio requirement (sum of Lines 5A, 5B, 5C, and/or 5D, as applicable) (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM34 | 2021-10-06 | 9999-12-31 | Calculation of Minimum Net Capital Requirement: Net capital and tentative net capital in relation to early warning thresholds: Net capital in excess of 120% of minimum net capital requirement reported on Line 7 (Reported by a: Stand-Alone Broker-Dealer; Broker-Dealer SBSD (other than OTC Derivatives Dealer); Broker-Dealer MSBSP) | SEC 1695/1696 |
| SECFNM35 | 2021-10-06 | 9999-12-31 | Calculation of Excess Tentative Net Capital (If Applicable): Fixed-dollar minimum tentative net capital requirement (Reported by a: Stand-Alone SBSD; SBSD registered as an OTC Derivatives Dealer) | SEC 1695/1696 |
| SECFNM36 | 2021-10-06 | 9999-12-31 | Calculation of Excess Tentative Net Capital (If Applicable): Excess tentative net capital (difference between Lines 1 and 2) (Reported by a: Stand-Alone SBSD; SBSD registered as an OTC Derivatives Dealer) | SEC 1695/1696 |
| SECFNM37 | 2021-10-06 | 9999-12-31 | Calculation of Excess Tentative Net Capital (If Applicable): Tentative net capital in excess of 120% of minimum tentative net capital requirements reported on Line 2 (Reported by a: Stand-Alone SBSD; SBSD registered as an OTC Derivatives Dealer) | SEC 1695/1696 |
| SECFNM38 | 2021-10-06 | 9999-12-31 | Calculation of Minimum Net Capital Requirement: Ratio minimum net capital requirement - Percentage of risk margin amount computed under 17 CFR 240.18a-1(a)(1) (Reported by a: Stand-Alone SBSD; SBSD registered as an OTC Derivatives Dealer) | SEC 1695/1696 |
| SECFNM39 | 2021-10-06 | 9999-12-31 | Calculation of Minimum Net Capital Requirement: Net capital in excess of 120% of minimum net capital requirement reported on Line 7 (Line Item 3750 - [Line Item 3760 x 120%]) (Reported by a: Stand-Alone SBSD; SBSD registered as an OTC Derivatives Dealer) | SEC 1695/1696 |
| SECFNM40 | 2021-10-06 | 9999-12-31 | Computation of Tangible Net Worth: Goodwill and other intangible assets | SEC 1695/1696 |
| SECFNM41 | 2021-10-06 | 9999-12-31 | Computation of Tangible Net Worth: Tangible net worth (Line 1 minus Line 2) | SEC 1695/1696 |
| SECFNM42 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Free credit balances and other credit balances in the accounts carried for security-based swap customers (see Note A) | SEC 1695/1696 |
| SECFNM43 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Monies borrowed collateralized by securities in accounts carried for security-based swap customers (see Note B) | SEC 1695/1696 |
| SECFNM44 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Monies payable against security-based swap customers' securities loaned (see Note C) | SEC 1695/1696 |
| SECFNM45 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Security-based swap customers' securities failed to receive (see Note D) | SEC 1695/1696 |
| SECFNM46 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Credit balances in firm accounts attributable to principal sales to security-based swap customers | SEC 1695/1696 |
| SECFNM47 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Market value of stock dividends, stock splits and similar distributions receivable outstanding over 30 calendar days | SEC 1695/1696 |
| SECFNM48 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Market value of short security count differences over 30 calendar days old | SEC 1695/1696 |
| SECFNM49 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Market value of short securities and credits (not to be offset by longs or by debits) in all suspense accounts over 30 calendar days | SEC 1695/1696 |
| SECFNM50 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Market value of securities which are in transfer in excess of 40 calendar days and have not been confirmed to be in transfer by the transfer agent or the issuer during the 40 days | SEC 1695/1696 |
| SECFNM51 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Other | SEC 1695/1696 |
| SECFNM52 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Credit Balances: Total credits (sum of Lines 1-10) | SEC 1695/1696 |
| SECFNM53 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Debit balances in accounts carried for security-based swap customers, excluding unsecured accounts and accounts doubtful of collection (see Note E) | SEC 1695/1696 |
| SECFNM54 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Securities borrowed to effectuate short sales by security-based swap customers and securities borrowed to make delivery on security-based swap customers' securities failed to deliver | SEC 1695/1696 |
| SECFNM55 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Failed to deliver of security-based swap customers' securities not older than 30 calendar days | SEC 1695/1696 |
| SECFNM56 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Margin required and on deposit with Options Clearing Corporation for all option contracts written or purchased in accounts carried for security-based swap customers (see Note F) | SEC 1695/1696 |
| SECFNM57 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Margin related to security future products written, purchased or sold in accounts carried for security- based swap customers required and on deposit in a qualified clearing agency account at a clearing agency registered with the Commission under section 17A of the Exchange Act (15 U.S.C. 78q-1) or a derivative clearing organization registered with the Commodity Futures Trading Commission under section 5b of the Commodity Exchange Act (7 U.S.C. 7a-1) (see Note G) | SEC 1695/1696 |
| SECFNM58 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Margin related to cleared security-based swap transactions in accounts carried for security-based swap customers required and on deposit in a qualified clearing agency account at a clearing agency registered with the Commission pursuant to section 17A of the Exchange Act (15 U.S.C. 78q-1) | SEC 1695/1696 |
| SECFNM59 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Margin related to non-cleared security-based swap transactions in accounts carried for security-based swap customers required and held in a qualified registered security-based swap dealer account at another security-based swap dealer | SEC 1695/1696 |
| SECFNM60 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Other | SEC 1695/1696 |
| SECFNM61 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Aggregate debit items | SEC 1695/1696 |
| SECFNM62 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Debit Balances: Total debits (sum of Lines 12-19) | SEC 1695/1696 |
| SECFNM63 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Reserve Computation: Reserve Computation: Excess of total debits over total credits (Line 21 less Line 11) | SEC 1695/1696 |
| SECFNM64 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Reserve Computation: Excess of total credits over total debits (Line 11 less Line 21) | SEC 1695/1696 |
| SECFNM65 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Reserve Computation: Amount held on deposit in "Reserve Account(s)," including value of qualified securities, at end of reporting period | SEC 1695/1696 |
| SECFNM66 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Reserve Computation: Amount of deposit (or withdrawal) | SEC 1695/1696 |
| SECFNM67 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Value of qualified securities of amount of deposit | SEC 1695/1696 |
| SECFNM68 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: New amount in Reserve Account(s) after adding deposit or subtracting withdrawal | SEC 1695/1696 |
| SECFNM69 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Value of qualified securities of new amount in Reserve Account(s) after adding deposit or subtracting withdrawal | SEC 1695/1696 |
| SECFNM70 | 2021-10-06 | 9999-12-31 | Computation for Determination of Security-based Swap Customer Reserve Requirements: Date of deposit (MM/DD/YY) | SEC 1695/1696 |
| SECFNM71 | 2021-10-06 | 9999-12-31 | Possession or control for security-based swap customers: State the market valuation and number of items: Security-based swap customers' excess securities collateral not in the respondent's possession or control as of the report date (for which instructions to reduce to possession or control had been issued as of the report date) but for which the required action was not taken by respondent within the time frame specified under Rule 15c3-3(p) or Rule 18a-4, as applicable. Notes A and B | SEC 1695/1696 |
| SECFNM72 | 2021-10-06 | 9999-12-31 | Possession or control for security-based swap customers: State the market valuation and number of items: Security-based swap customers' excess securities collateral not in the respondent's possession or control as of the report date (for which instructions to reduce to possession or control had been issued as of the report date) but for which the required action was not taken by respondent within the time frame specified under Rule 15c3-3(p) or Rule 18a-4, as applicable. Notes A and B: Number of items | SEC 1695/1696 |
| SECFNM73 | 2021-10-06 | 9999-12-31 | Possession or control for security-based swap customers: State the market valuation and number of items: Security-based swap customers' excess securities collateral for which instructions to reduce possession or control had not been issued as of the report date under Rule 15c3-3(p) or Rule 18a-4, as applicable. | SEC 1695/1696 |
| SECFNM74 | 2021-10-06 | 9999-12-31 | Possession or control for security-based swap customers: State the market valuation and number of items: Security-based swap customers' excess securities collateral for which instructions to reduce possession or control had not been issued as of the report date under Rule 15c3-3(p) or Rule 18a-4, as applicable: Number of items | SEC 1695/1696 |
| SECFNM75 | 2021-10-06 | 9999-12-31 | Possession or control for security-based swap customers: State the market valuation and number of items: The system and procedures utilized in complying with the requirement to maintain physical possession or control of security-based swap customers' excess securities collateral have been tested and are functioning in a manner adequate to fulfill the requirements of Rule 15c3-3(p) or Rule 18a-4, as applicable: Yes | SEC 1695/1696 |
| SECFNM76 | 2021-10-06 | 9999-12-31 | Possession or control for security-based swap customers: State the market valuation and number of items: The system and procedures utilized in complying with the requirement to maintain physical possession or control of security-based swap customers' excess securities collateral have been tested and are functioning in a manner adequate to fulfill the requirements of Rule 15c3-3(p) or Rule 18a-4, as applicable: No | SEC 1695/1696 |
| SECFNM77 | 2021-10-06 | 9999-12-31 | Claiming an exemption from Rule 18a-4: If an exemption from Rule 18a-4 is claimed, check the box | SEC 1695/1696 |
| SECFNM78 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: U.S. government agency and U.S. government-sponsored enterprises: Mortgage-backed securities issued by U.S. government agency and U.S. government-sponsored enterprises - Long / Bought | SEC 1695/1696 |
| SECFNM79 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: U.S. government agency and U.S. government-sponsored enterprises: Mortgage-backed securities issued by U.S. government agency and U.S. government-sponsored enterprises - Short / Sold | SEC 1695/1696 |
| SECFNM80 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: U.S. government agency and U.S. government-sponsored enterprises: Debt securities issued by U.S. government agency and U.S. government-sponsored enterprises - Long / Bought | SEC 1695/1696 |
| SECFNM81 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: U.S. government agency and U.S. government-sponsored enterprises: Debt securities issued by U.S. government agency and U.S. government-sponsored enterprises - Short / Sold | SEC 1695/1696 |
| SECFNM82 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Securities with no ready market: Total securities with no ready market - Long / Bought | SEC 1695/1696 |
| SECFNM83 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Securities with no ready market: Total securities with no ready market - Short / Sold | SEC 1695/1696 |
| SECFNM84 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Total net securities and spot commodities (sum of Lines 1-12 and 13D) - Long / Bought | SEC 1695/1696 |
| SECFNM85 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Total net securities and spot commodities (sum of Lines 1-12 and 13D) - Short / Sold | SEC 1695/1696 |
| SECFNM86 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Security-based swaps: Cleared - Long / Bought | SEC 1695/1696 |
| SECFNM87 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Security-based swaps: Cleared - Short / Sold | SEC 1695/1696 |
| SECFNM88 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Security-based swaps: Non-cleared - Long / Bought | SEC 1695/1696 |
| SECFNM89 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Security-based swaps: Non-cleared - Short / Sold | SEC 1695/1696 |
| SECFNM90 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Mixed swaps: Cleared - Long / Bought | SEC 1695/1696 |
| SECFNM91 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Mixed swaps: Cleared - Short / Sold | SEC 1695/1696 |
| SECFNM92 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Mixed swaps: Non-cleared - Long / Bought | SEC 1695/1696 |
| SECFNM93 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Mixed swaps: Non-cleared - Short / Sold | SEC 1695/1696 |
| SECFNM94 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Swaps: Cleared - Long / Bought | SEC 1695/1696 |
| SECFNM95 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Swaps: Cleared - Short / Sold | SEC 1695/1696 |
| SECFNM96 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Swaps: Non-cleared - Long / Bought | SEC 1695/1696 |
| SECFNM97 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Swaps: Non-cleared - Short / Sold | SEC 1695/1696 |
| SECFNM98 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Counterparty netting - Long / Bought | SEC 1695/1696 |
| SECFNM99 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Counterparty netting - Short / Sold | SEC 1695/1696 |
| SECFNN00 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Cash collateral netting - Long / Bought | SEC 1695/1696 |
| SECFNN01 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Cash collateral netting - Short / Sold | SEC 1695/1696 |
| SECFNN02 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Total derivative receivables and payables (sum of Lines 15-20) - Long / Bought | SEC 1695/1696 |
| SECFNN03 | 2021-10-06 | 9999-12-31 | Schedule 1 Aggregate Securities, Commodities, and Swaps Positions: Total derivative receivables and payables (sum of Lines 15-20) - Short / Sold | SEC 1695/1696 |
| SECFNN04 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 1 | SEC 1695/1696 |
| SECFNN05 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 2 | SEC 1695/1696 |
| SECFNN06 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 3 | SEC 1695/1696 |
| SECFNN07 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 4 | SEC 1695/1696 |
| SECFNN08 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 5 | SEC 1695/1696 |
| SECFNN09 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 6 | SEC 1695/1696 |
| SECFNN10 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 7 | SEC 1695/1696 |
| SECFNN11 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 8 | SEC 1695/1696 |
| SECFNN12 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 9 | SEC 1695/1696 |
| SECFNN13 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 10 | SEC 1695/1696 |
| SECFNN14 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 11 | SEC 1695/1696 |
| SECFNN15 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 12 | SEC 1695/1696 |
| SECFNN16 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 13 | SEC 1695/1696 |
| SECFNN17 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 14 | SEC 1695/1696 |
| SECFNN18 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Counterparty Identifier Row 15 | SEC 1695/1696 |
| SECFNN19 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 1 | SEC 1695/1696 |
| SECFNN20 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 2 | SEC 1695/1696 |
| SECFNN21 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 3 | SEC 1695/1696 |
| SECFNN22 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 4 | SEC 1695/1696 |
| SECFNN23 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 5 | SEC 1695/1696 |
| SECFNN24 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 6 | SEC 1695/1696 |
| SECFNN25 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 7 | SEC 1695/1696 |
| SECFNN26 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 8 | SEC 1695/1696 |
| SECFNN27 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 9 | SEC 1695/1696 |
| SECFNN28 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 10 | SEC 1695/1696 |
| SECFNN29 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 11 | SEC 1695/1696 |
| SECFNN30 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 12 | SEC 1695/1696 |
| SECFNN31 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 13 | SEC 1695/1696 |
| SECFNN32 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 14 | SEC 1695/1696 |
| SECFNN33 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 15 | SEC 1695/1696 |
| SECFNN34 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Receivable (Gross Gain) - All other counterparties | SEC 1695/1696 |
| SECFNN35 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 1 | SEC 1695/1696 |
| SECFNN36 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 2 | SEC 1695/1696 |
| SECFNN37 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 3 | SEC 1695/1696 |
| SECFNN38 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 4 | SEC 1695/1696 |
| SECFNN39 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 5 | SEC 1695/1696 |
| SECFNN40 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 6 | SEC 1695/1696 |
| SECFNN41 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 7 | SEC 1695/1696 |
| SECFNN42 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 8 | SEC 1695/1696 |
| SECFNN43 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 9 | SEC 1695/1696 |
| SECFNN44 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 10 | SEC 1695/1696 |
| SECFNN45 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 11 | SEC 1695/1696 |
| SECFNN46 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 12 | SEC 1695/1696 |
| SECFNN47 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 13 | SEC 1695/1696 |
| SECFNN48 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 14 | SEC 1695/1696 |
| SECFNN49 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) Row 15 | SEC 1695/1696 |
| SECFNN50 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Payable (Gross Loss) - All other counterparties | SEC 1695/1696 |
| SECFNN51 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 1 | SEC 1695/1696 |
| SECFNN52 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 2 | SEC 1695/1696 |
| SECFNN53 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 3 | SEC 1695/1696 |
| SECFNN54 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 4 | SEC 1695/1696 |
| SECFNN55 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 5 | SEC 1695/1696 |
| SECFNN56 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 6 | SEC 1695/1696 |
| SECFNN57 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 7 | SEC 1695/1696 |
| SECFNN58 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 8 | SEC 1695/1696 |
| SECFNN59 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 9 | SEC 1695/1696 |
| SECFNN60 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 10 | SEC 1695/1696 |
| SECFNN61 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 11 | SEC 1695/1696 |
| SECFNN62 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 12 | SEC 1695/1696 |
| SECFNN63 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 13 | SEC 1695/1696 |
| SECFNN64 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 14 | SEC 1695/1696 |
| SECFNN65 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value Row 15 | SEC 1695/1696 |
| SECFNN66 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Net Replacement Value - All other counterparties | SEC 1695/1696 |
| SECFNN67 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 1 | SEC 1695/1696 |
| SECFNN68 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 2 | SEC 1695/1696 |
| SECFNN69 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 3 | SEC 1695/1696 |
| SECFNN70 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 4 | SEC 1695/1696 |
| SECFNN71 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 5 | SEC 1695/1696 |
| SECFNN72 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 6 | SEC 1695/1696 |
| SECFNN73 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 7 | SEC 1695/1696 |
| SECFNN74 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 8 | SEC 1695/1696 |
| SECFNN75 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 9 | SEC 1695/1696 |
| SECFNN76 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 10 | SEC 1695/1696 |
| SECFNN77 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 11 | SEC 1695/1696 |
| SECFNN78 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 12 | SEC 1695/1696 |
| SECFNN79 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 13 | SEC 1695/1696 |
| SECFNN80 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 14 | SEC 1695/1696 |
| SECFNN81 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure Row 15 | SEC 1695/1696 |
| SECFNN82 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net Exposure - All other counterparties | SEC 1695/1696 |
| SECFNN83 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 1 | SEC 1695/1696 |
| SECFNN84 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 2 | SEC 1695/1696 |
| SECFNN85 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 3 | SEC 1695/1696 |
| SECFNN86 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 4 | SEC 1695/1696 |
| SECFNN87 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 5 | SEC 1695/1696 |
| SECFNN88 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 6 | SEC 1695/1696 |
| SECFNN89 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 7 | SEC 1695/1696 |
| SECFNN90 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 8 | SEC 1695/1696 |
| SECFNN91 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 9 | SEC 1695/1696 |
| SECFNN92 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 10 | SEC 1695/1696 |
| SECFNN93 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 11 | SEC 1695/1696 |
| SECFNN94 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 12 | SEC 1695/1696 |
| SECFNN95 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 13 | SEC 1695/1696 |
| SECFNN96 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 14 | SEC 1695/1696 |
| SECFNN97 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 15 | SEC 1695/1696 |
| SECFNN98 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Current Net and Potential Exposure- All other counterparties | SEC 1695/1696 |
| SECFNN99 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 1 | SEC 1695/1696 |
| SECFNP00 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 2 | SEC 1695/1696 |
| SECFNP01 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 3 | SEC 1695/1696 |
| SECFNP02 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 4 | SEC 1695/1696 |
| SECFNP03 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 5 | SEC 1695/1696 |
| SECFNP04 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 6 | SEC 1695/1696 |
| SECFNP05 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 7 | SEC 1695/1696 |
| SECFNP06 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 8 | SEC 1695/1696 |
| SECFNP07 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 9 | SEC 1695/1696 |
| SECFNP08 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 10 | SEC 1695/1696 |
| SECFNP09 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 11 | SEC 1695/1696 |
| SECFNP10 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 12 | SEC 1695/1696 |
| SECFNP11 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 13 | SEC 1695/1696 |
| SECFNP12 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 14 | SEC 1695/1696 |
| SECFNP13 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected Row 15 | SEC 1695/1696 |
| SECFNP14 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected- All other counterparties | SEC 1695/1696 |
| SECFNP15 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net Exposure: Gross Replacement Value - Margin Collected - Totals | SEC 1695/1696 |
| SECFNP16 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 1 | SEC 1695/1696 |
| SECFNP17 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 2 | SEC 1695/1696 |
| SECFNP18 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 3 | SEC 1695/1696 |
| SECFNP19 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 4 | SEC 1695/1696 |
| SECFNP20 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 5 | SEC 1695/1696 |
| SECFNP21 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 6 | SEC 1695/1696 |
| SECFNP22 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 7 | SEC 1695/1696 |
| SECFNP23 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 8 | SEC 1695/1696 |
| SECFNP24 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 9 | SEC 1695/1696 |
| SECFNP25 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 10 | SEC 1695/1696 |
| SECFNP26 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 11 | SEC 1695/1696 |
| SECFNP27 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 12 | SEC 1695/1696 |
| SECFNP28 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 13 | SEC 1695/1696 |
| SECFNP29 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 14 | SEC 1695/1696 |
| SECFNP30 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Counterparty Identifier Row 15 | SEC 1695/1696 |
| SECFNP31 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 1 | SEC 1695/1696 |
| SECFNP32 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 2 | SEC 1695/1696 |
| SECFNP33 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 3 | SEC 1695/1696 |
| SECFNP34 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 4 | SEC 1695/1696 |
| SECFNP35 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 5 | SEC 1695/1696 |
| SECFNP36 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 6 | SEC 1695/1696 |
| SECFNP37 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 7 | SEC 1695/1696 |
| SECFNP38 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 8 | SEC 1695/1696 |
| SECFNP39 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 9 | SEC 1695/1696 |
| SECFNP40 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 10 | SEC 1695/1696 |
| SECFNP41 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 11 | SEC 1695/1696 |
| SECFNP42 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 12 | SEC 1695/1696 |
| SECFNP43 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 13 | SEC 1695/1696 |
| SECFNP44 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 14 | SEC 1695/1696 |
| SECFNP45 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) Row 15 | SEC 1695/1696 |
| SECFNP46 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Receivable (Gross Gain) - All other counterparties | SEC 1695/1696 |
| SECFNP47 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) - Total | SEC 1695/1696 |
| SECFNP48 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 1 | SEC 1695/1696 |
| SECFNP49 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 2 | SEC 1695/1696 |
| SECFNP50 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 3 | SEC 1695/1696 |
| SECFNP51 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 4 | SEC 1695/1696 |
| SECFNP52 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 5 | SEC 1695/1696 |
| SECFNP53 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 6 | SEC 1695/1696 |
| SECFNP54 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 7 | SEC 1695/1696 |
| SECFNP55 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 8 | SEC 1695/1696 |
| SECFNP56 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 9 | SEC 1695/1696 |
| SECFNP57 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 10 | SEC 1695/1696 |
| SECFNP58 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 11 | SEC 1695/1696 |
| SECFNP59 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 12 | SEC 1695/1696 |
| SECFNP60 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 13 | SEC 1695/1696 |
| SECFNP61 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 14 | SEC 1695/1696 |
| SECFNP62 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) Row 15 | SEC 1695/1696 |
| SECFNP63 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) - All other counterparties | SEC 1695/1696 |
| SECFNP64 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Payable (Gross Loss) - Totals | SEC 1695/1696 |
| SECFNP65 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 1 | SEC 1695/1696 |
| SECFNP66 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 2 | SEC 1695/1696 |
| SECFNP67 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 3 | SEC 1695/1696 |
| SECFNP68 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 4 | SEC 1695/1696 |
| SECFNP69 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 5 | SEC 1695/1696 |
| SECFNP70 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 6 | SEC 1695/1696 |
| SECFNP71 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 7 | SEC 1695/1696 |
| SECFNP72 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 8 | SEC 1695/1696 |
| SECFNP73 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 9 | SEC 1695/1696 |
| SECFNP74 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 10 | SEC 1695/1696 |
| SECFNP75 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 11 | SEC 1695/1696 |
| SECFNP76 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 12 | SEC 1695/1696 |
| SECFNP77 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 13 | SEC 1695/1696 |
| SECFNP78 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 14 | SEC 1695/1696 |
| SECFNP79 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value Row 15 | SEC 1695/1696 |
| SECFNP80 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value - All other counterparties | SEC 1695/1696 |
| SECFNP81 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Net Replacement Value -Totals | SEC 1695/1696 |
| SECFNP82 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 1 | SEC 1695/1696 |
| SECFNP83 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 2 | SEC 1695/1696 |
| SECFNP84 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 3 | SEC 1695/1696 |
| SECFNP85 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 4 | SEC 1695/1696 |
| SECFNP86 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 5 | SEC 1695/1696 |
| SECFNP87 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 6 | SEC 1695/1696 |
| SECFNP88 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 7 | SEC 1695/1696 |
| SECFNP89 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 8 | SEC 1695/1696 |
| SECFNP90 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 9 | SEC 1695/1696 |
| SECFNP91 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 10 | SEC 1695/1696 |
| SECFNP92 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 11 | SEC 1695/1696 |
| SECFNP93 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 12 | SEC 1695/1696 |
| SECFNP94 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 13 | SEC 1695/1696 |
| SECFNP95 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 14 | SEC 1695/1696 |
| SECFNP96 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure Row 15 | SEC 1695/1696 |
| SECFNP97 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure - All other counterparties | SEC 1695/1696 |
| SECFNP98 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net Exposure -Totals | SEC 1695/1696 |
| SECFNP99 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 1 | SEC 1695/1696 |
| SECFNQ00 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 2 | SEC 1695/1696 |
| SECFNQ01 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 3 | SEC 1695/1696 |
| SECFNQ02 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 4 | SEC 1695/1696 |
| SECFNQ03 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 5 | SEC 1695/1696 |
| SECFNQ04 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 6 | SEC 1695/1696 |
| SECFNQ05 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 7 | SEC 1695/1696 |
| SECFNQ06 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 8 | SEC 1695/1696 |
| SECFNQ07 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 9 | SEC 1695/1696 |
| SECFNQ08 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 10 | SEC 1695/1696 |
| SECFNQ09 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 11 | SEC 1695/1696 |
| SECFNQ10 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 12 | SEC 1695/1696 |
| SECFNQ11 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 13 | SEC 1695/1696 |
| SECFNQ12 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 14 | SEC 1695/1696 |
| SECFNQ13 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure Row 15 | SEC 1695/1696 |
| SECFNQ14 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure- All other counterparties | SEC 1695/1696 |
| SECFNQ15 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Current Net and Potential Exposure- Totals | SEC 1695/1696 |
| SECFNQ16 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 1 | SEC 1695/1696 |
| SECFNQ17 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 2 | SEC 1695/1696 |
| SECFNQ18 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 3 | SEC 1695/1696 |
| SECFNQ19 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 4 | SEC 1695/1696 |
| SECFNQ20 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 5 | SEC 1695/1696 |
| SECFNQ21 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 6 | SEC 1695/1696 |
| SECFNQ22 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 7 | SEC 1695/1696 |
| SECFNQ23 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 8 | SEC 1695/1696 |
| SECFNQ24 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 9 | SEC 1695/1696 |
| SECFNQ25 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 10 | SEC 1695/1696 |
| SECFNQ26 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 11 | SEC 1695/1696 |
| SECFNQ27 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 12 | SEC 1695/1696 |
| SECFNQ28 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 13 | SEC 1695/1696 |
| SECFNQ29 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 14 | SEC 1695/1696 |
| SECFNQ30 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected Row 15 | SEC 1695/1696 |
| SECFNQ31 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected- All other counterparties | SEC 1695/1696 |
| SECFNQ32 | 2021-10-06 | 9999-12-31 | Schedule 2 Credit concentration report for fifteen largest exposures in derivatives: By Current Net and Potential Exposure: Gross Replacement Value - Margin Collected - Totals | SEC 1695/1696 |
| SECFNS94 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 7 | SEC 1695/1696 |
| SECFNS95 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 8 | SEC 1695/1696 |
| SECFNS96 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 9 | SEC 1695/1696 |
| SECFNS97 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 10 | SEC 1695/1696 |
| SECFNS98 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 11 | SEC 1695/1696 |
| SECFNS99 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 12 | SEC 1695/1696 |
| SECFNT00 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 13 | SEC 1695/1696 |
| SECFNT01 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 14 | SEC 1695/1696 |
| SECFNT02 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 15 | SEC 1695/1696 |
| SECFNT03 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 16 | SEC 1695/1696 |
| SECFNT04 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 17 | SEC 1695/1696 |
| SECFNT05 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 18 | SEC 1695/1696 |
| SECFNT06 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 19 | SEC 1695/1696 |
| SECFNT07 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 20 | SEC 1695/1696 |
| SECFNT08 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 21 | SEC 1695/1696 |
| SECFNT09 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 22 | SEC 1695/1696 |
| SECFNT10 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 23 | SEC 1695/1696 |
| SECFNT11 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 24 | SEC 1695/1696 |
| SECFNT12 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 25 | SEC 1695/1696 |
| SECFNT13 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 26 | SEC 1695/1696 |
| SECFNT14 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 27 | SEC 1695/1696 |
| SECFNT15 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 28 | SEC 1695/1696 |
| SECFNT16 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 29 | SEC 1695/1696 |
| SECFNT17 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 30 | SEC 1695/1696 |
| SECFNT18 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 31 | SEC 1695/1696 |
| SECFNT19 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 32 | SEC 1695/1696 |
| SECFNT20 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 33 | SEC 1695/1696 |
| SECFNT21 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 34 | SEC 1695/1696 |
| SECFNT22 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 35 | SEC 1695/1696 |
| SECFNT23 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 36 | SEC 1695/1696 |
| SECFNT24 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected - Unrated | SEC 1695/1696 |
| SECFNT25 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected - Totals | SEC 1695/1696 |
| SECFNT26 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 1 | SEC 1695/1696 |
| SECFNT27 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 2 | SEC 1695/1696 |
| SECFNT28 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 3 | SEC 1695/1696 |
| SECFNT29 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 4 | SEC 1695/1696 |
| SECFNT30 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 5 | SEC 1695/1696 |
| SECFNT31 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 6 | SEC 1695/1696 |
| SECFNT32 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 7 | SEC 1695/1696 |
| SECFNT33 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 8 | SEC 1695/1696 |
| SECFNT34 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 9 | SEC 1695/1696 |
| SECFNT35 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Country Row 10 | SEC 1695/1696 |
| SECFNT36 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 1 | SEC 1695/1696 |
| SECFNT37 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 2 | SEC 1695/1696 |
| SECFNT38 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 3 | SEC 1695/1696 |
| SECFNT39 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 4 | SEC 1695/1696 |
| SECFNT40 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 5 | SEC 1695/1696 |
| SECFNT41 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 6 | SEC 1695/1696 |
| SECFNT42 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 7 | SEC 1695/1696 |
| SECFNT43 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 8 | SEC 1695/1696 |
| SECFNT44 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 9 | SEC 1695/1696 |
| SECFNT45 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Receivable Row 10 | SEC 1695/1696 |
| SECFNT46 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 1 | SEC 1695/1696 |
| SECFNT47 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 2 | SEC 1695/1696 |
| SECFNT48 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 3 | SEC 1695/1696 |
| SECFNT49 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 4 | SEC 1695/1696 |
| SECFNT50 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 5 | SEC 1695/1696 |
| SECFNT51 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 6 | SEC 1695/1696 |
| SECFNT52 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 7 | SEC 1695/1696 |
| SECFNT53 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 8 | SEC 1695/1696 |
| SECFNT54 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 9 | SEC 1695/1696 |
| SECFNT55 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Gross Replacement Value Payable Row 10 | SEC 1695/1696 |
| SECFNT56 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 1 | SEC 1695/1696 |
| SECFNT57 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 2 | SEC 1695/1696 |
| SECFNT58 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 3 | SEC 1695/1696 |
| SECFNT59 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 4 | SEC 1695/1696 |
| SECFNT60 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 5 | SEC 1695/1696 |
| SECFNT61 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 6 | SEC 1695/1696 |
| SECFNT62 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 7 | SEC 1695/1696 |
| SECFNT63 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 8 | SEC 1695/1696 |
| SECFNT64 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 9 | SEC 1695/1696 |
| SECFNT65 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Net Replacement Value Row 10 | SEC 1695/1696 |
| SECFNT66 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 1 | SEC 1695/1696 |
| SECFNT67 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 2 | SEC 1695/1696 |
| SECFNT68 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 3 | SEC 1695/1696 |
| SECFNT69 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 4 | SEC 1695/1696 |
| SECFNT70 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 5 | SEC 1695/1696 |
| SECFNT71 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 6 | SEC 1695/1696 |
| SECFNT72 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 7 | SEC 1695/1696 |
| SECFNT73 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 8 | SEC 1695/1696 |
| SECFNT74 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 9 | SEC 1695/1696 |
| SECFNT75 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure Row 10 | SEC 1695/1696 |
| SECFNT76 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net Exposure - Totals | SEC 1695/1696 |
| SECFNT77 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 1 | SEC 1695/1696 |
| SECFNT78 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 2 | SEC 1695/1696 |
| SECFNT79 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 3 | SEC 1695/1696 |
| SECFNT80 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 4 | SEC 1695/1696 |
| SECFNT81 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 5 | SEC 1695/1696 |
| SECFNT82 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 6 | SEC 1695/1696 |
| SECFNT83 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 7 | SEC 1695/1696 |
| SECFNT84 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 8 | SEC 1695/1696 |
| SECFNT85 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 9 | SEC 1695/1696 |
| SECFNT86 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Current Net and Potential Exposure Row 10 | SEC 1695/1696 |
| SECFNT87 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 1 | SEC 1695/1696 |
| SECFNT88 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 2 | SEC 1695/1696 |
| SECFNT89 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 3 | SEC 1695/1696 |
| SECFNT90 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 4 | SEC 1695/1696 |
| SECFNT91 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 5 | SEC 1695/1696 |
| SECFNT92 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 6 | SEC 1695/1696 |
| SECFNT93 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 7 | SEC 1695/1696 |
| SECFNT94 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 8 | SEC 1695/1696 |
| SECFNT95 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 9 | SEC 1695/1696 |
| SECFNT96 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected Row 10 | SEC 1695/1696 |
| SECFNT97 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net exposure: Margin Collected - Totals | SEC 1695/1696 |
| SECFNT98 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 1 | SEC 1695/1696 |
| SECFNT99 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 2 | SEC 1695/1696 |
| SECFNU00 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 3 | SEC 1695/1696 |
| SECFNU01 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 4 | SEC 1695/1696 |
| SECFNU02 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 5 | SEC 1695/1696 |
| SECFNU03 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 6 | SEC 1695/1696 |
| SECFNU04 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 7 | SEC 1695/1696 |
| SECFNU05 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 8 | SEC 1695/1696 |
| SECFNU06 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 9 | SEC 1695/1696 |
| SECFNU07 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Country Row 10 | SEC 1695/1696 |
| SECFNU08 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 1 | SEC 1695/1696 |
| SECFNU09 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 2 | SEC 1695/1696 |
| SECFNU10 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 3 | SEC 1695/1696 |
| SECFNU11 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 4 | SEC 1695/1696 |
| SECFNU12 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 5 | SEC 1695/1696 |
| SECFNU13 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 6 | SEC 1695/1696 |
| SECFNU14 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 7 | SEC 1695/1696 |
| SECFNU15 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 8 | SEC 1695/1696 |
| SECFNU16 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 9 | SEC 1695/1696 |
| SECFNU17 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable Row 10 | SEC 1695/1696 |
| SECFNU18 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Receivable - Totals | SEC 1695/1696 |
| SECFNU19 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 1 | SEC 1695/1696 |
| SECFNU20 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 2 | SEC 1695/1696 |
| SECFNU21 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 3 | SEC 1695/1696 |
| SECFNU22 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 4 | SEC 1695/1696 |
| SECFNU23 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 5 | SEC 1695/1696 |
| SECFNU24 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 6 | SEC 1695/1696 |
| SECFNU25 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 7 | SEC 1695/1696 |
| SECFNU26 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 8 | SEC 1695/1696 |
| SECFNU27 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 9 | SEC 1695/1696 |
| SECFNU28 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable Row 10 | SEC 1695/1696 |
| SECFNU29 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Gross Replacement Value Payable - Totals | SEC 1695/1696 |
| SECFNU30 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 1 | SEC 1695/1696 |
| SECFNU31 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 2 | SEC 1695/1696 |
| SECFNU32 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 3 | SEC 1695/1696 |
| SECFNU33 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 4 | SEC 1695/1696 |
| SECFNU34 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 5 | SEC 1695/1696 |
| SECFNU35 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 6 | SEC 1695/1696 |
| SECFNU36 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 7 | SEC 1695/1696 |
| SECFNU37 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 8 | SEC 1695/1696 |
| SECFNU38 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 9 | SEC 1695/1696 |
| SECFNU39 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value Row 10 | SEC 1695/1696 |
| SECFNU40 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Net Replacement Value - Totals | SEC 1695/1696 |
| SECFNU41 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 1 | SEC 1695/1696 |
| SECFNU42 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 2 | SEC 1695/1696 |
| SECFNU43 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 3 | SEC 1695/1696 |
| SECFNU44 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 4 | SEC 1695/1696 |
| SECFNU45 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 5 | SEC 1695/1696 |
| SECFNU46 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 6 | SEC 1695/1696 |
| SECFNU47 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 7 | SEC 1695/1696 |
| SECFNU48 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 8 | SEC 1695/1696 |
| SECFNU49 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 9 | SEC 1695/1696 |
| SECFNU50 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure Row 10 | SEC 1695/1696 |
| SECFNU51 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net Exposure - Totals | SEC 1695/1696 |
| SECFNU52 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 1 | SEC 1695/1696 |
| SECFNU53 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 2 | SEC 1695/1696 |
| SECFNU54 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 3 | SEC 1695/1696 |
| SECFNU55 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 4 | SEC 1695/1696 |
| SECFNU56 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 5 | SEC 1695/1696 |
| SECFNU57 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 6 | SEC 1695/1696 |
| SECFNU58 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 7 | SEC 1695/1696 |
| SECFNU59 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 8 | SEC 1695/1696 |
| SECFNU60 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 9 | SEC 1695/1696 |
| SECFNU61 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure Row 10 | SEC 1695/1696 |
| SECFNU62 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Current Net and Potential Exposure - Totals | SEC 1695/1696 |
| SECFNU63 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 1 | SEC 1695/1696 |
| SECFNU64 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 2 | SEC 1695/1696 |
| SECFNU65 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 3 | SEC 1695/1696 |
| SECFNU66 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 4 | SEC 1695/1696 |
| SECFNU67 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 5 | SEC 1695/1696 |
| SECFNU68 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 6 | SEC 1695/1696 |
| SECFNU69 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 7 | SEC 1695/1696 |
| SECFNU70 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 8 | SEC 1695/1696 |
| SECFNU71 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 9 | SEC 1695/1696 |
| SECFNU72 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected Row 10 | SEC 1695/1696 |
| SECFNU73 | 2021-10-06 | 9999-12-31 | Schedule 4 Geographic distribution of derivatives exposures for ten largest countries: By current net and potential exposure: Margin Collected - Totals | SEC 1695/1696 |
| SECFNX03 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 1 | SEC 1695/1696 |
| SECFNX04 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 2 | SEC 1695/1696 |
| SECFNX05 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 3 | SEC 1695/1696 |
| SECFNX06 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 4 | SEC 1695/1696 |
| SECFNX07 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 5 | SEC 1695/1696 |
| SECFNX08 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 6 | SEC 1695/1696 |
| SECFNX09 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 7 | SEC 1695/1696 |
| SECFNX10 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 8 | SEC 1695/1696 |
| SECFNX11 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 9 | SEC 1695/1696 |
| SECFNX12 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 10 | SEC 1695/1696 |
| SECFNX13 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 11 | SEC 1695/1696 |
| SECFNX14 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 12 | SEC 1695/1696 |
| SECFNX15 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 13 | SEC 1695/1696 |
| SECFNX16 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 14 | SEC 1695/1696 |
| SECFNX17 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 15 | SEC 1695/1696 |
| SECFNX18 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 16 | SEC 1695/1696 |
| SECFNX19 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 17 | SEC 1695/1696 |
| SECFNX20 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 18 | SEC 1695/1696 |
| SECFNX21 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 19 | SEC 1695/1696 |
| SECFNX22 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 20 | SEC 1695/1696 |
| SECFNX23 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 21 | SEC 1695/1696 |
| SECFNX24 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 22 | SEC 1695/1696 |
| SECFNX25 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 23 | SEC 1695/1696 |
| SECFNX26 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 24 | SEC 1695/1696 |
| SECFNX27 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 25 | SEC 1695/1696 |
| SECFNX28 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 26 | SEC 1695/1696 |
| SECFNX29 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 27 | SEC 1695/1696 |
| SECFNX30 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 28 | SEC 1695/1696 |
| SECFNX31 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 29 | SEC 1695/1696 |
| SECFNX32 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 30 | SEC 1695/1696 |
| SECFNX33 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 31 | SEC 1695/1696 |
| SECFNX34 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 32 | SEC 1695/1696 |
| SECFNX35 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 33 | SEC 1695/1696 |
| SECFNX36 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 34 | SEC 1695/1696 |
| SECFNX37 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 35 | SEC 1695/1696 |
| SECFNX38 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating Row 36 | SEC 1695/1696 |
| SECFNX39 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Internal Credit Rating - Unrated | SEC 1695/1696 |
| SECFNX40 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 1 | SEC 1695/1696 |
| SECFNX41 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 2 | SEC 1695/1696 |
| SECFNX42 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 3 | SEC 1695/1696 |
| SECFNX43 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 4 | SEC 1695/1696 |
| SECFNX44 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 5 | SEC 1695/1696 |
| SECFNX45 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 6 | SEC 1695/1696 |
| SECFNX46 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 7 | SEC 1695/1696 |
| SECFNX47 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 8 | SEC 1695/1696 |
| SECFNX48 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 9 | SEC 1695/1696 |
| SECFNX49 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 10 | SEC 1695/1696 |
| SECFNX50 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 11 | SEC 1695/1696 |
| SECFNX51 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 12 | SEC 1695/1696 |
| SECFNX52 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 13 | SEC 1695/1696 |
| SECFNX53 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 14 | SEC 1695/1696 |
| SECFNX54 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 15 | SEC 1695/1696 |
| SECFNX55 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 16 | SEC 1695/1696 |
| SECFNX56 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 17 | SEC 1695/1696 |
| SECFNX57 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 18 | SEC 1695/1696 |
| SECFNX58 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 19 | SEC 1695/1696 |
| SECFNX59 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 20 | SEC 1695/1696 |
| SECFNX60 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 21 | SEC 1695/1696 |
| SECFNX61 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 22 | SEC 1695/1696 |
| SECFNX62 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 23 | SEC 1695/1696 |
| SECFNX63 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 24 | SEC 1695/1696 |
| SECFNX64 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 25 | SEC 1695/1696 |
| SECFNX65 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 26 | SEC 1695/1696 |
| SECFNX66 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 27 | SEC 1695/1696 |
| SECFNX67 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 28 | SEC 1695/1696 |
| SECFNX68 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 29 | SEC 1695/1696 |
| SECFNX69 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 30 | SEC 1695/1696 |
| SECFNX70 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 31 | SEC 1695/1696 |
| SECFNX71 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 32 | SEC 1695/1696 |
| SECFNX72 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 33 | SEC 1695/1696 |
| SECFNX73 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 34 | SEC 1695/1696 |
| SECFNX74 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 35 | SEC 1695/1696 |
| SECFNX75 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable Row 36 | SEC 1695/1696 |
| SECFNX76 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Receivable - Unrated | SEC 1695/1696 |
| SECFNX77 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 1 | SEC 1695/1696 |
| SECFNX78 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 2 | SEC 1695/1696 |
| SECFNX79 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 3 | SEC 1695/1696 |
| SECFNX80 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 4 | SEC 1695/1696 |
| SECFNX81 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 5 | SEC 1695/1696 |
| SECFNX82 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 6 | SEC 1695/1696 |
| SECFNX83 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 7 | SEC 1695/1696 |
| SECFNX84 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 8 | SEC 1695/1696 |
| SECFNX85 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 9 | SEC 1695/1696 |
| SECFNX86 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 10 | SEC 1695/1696 |
| SECFNX87 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 11 | SEC 1695/1696 |
| SECFNX88 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 12 | SEC 1695/1696 |
| SECFNX89 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 13 | SEC 1695/1696 |
| SECFNX90 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 14 | SEC 1695/1696 |
| SECFNX91 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 15 | SEC 1695/1696 |
| SECFNX92 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 16 | SEC 1695/1696 |
| SECFNX93 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 17 | SEC 1695/1696 |
| SECFNX94 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 18 | SEC 1695/1696 |
| SECFNX95 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 19 | SEC 1695/1696 |
| SECFNX96 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 20 | SEC 1695/1696 |
| SECFNX97 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 21 | SEC 1695/1696 |
| SECFNX98 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 22 | SEC 1695/1696 |
| SECFNX99 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 23 | SEC 1695/1696 |
| SECFNY00 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 24 | SEC 1695/1696 |
| SECFNY01 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 25 | SEC 1695/1696 |
| SECFNY02 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 26 | SEC 1695/1696 |
| SECFNY03 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 27 | SEC 1695/1696 |
| SECFNY04 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 28 | SEC 1695/1696 |
| SECFNY05 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 29 | SEC 1695/1696 |
| SECFNY06 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 30 | SEC 1695/1696 |
| SECFNY07 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 31 | SEC 1695/1696 |
| SECFNY08 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 32 | SEC 1695/1696 |
| SECFNY09 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 33 | SEC 1695/1696 |
| SECFNY10 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 34 | SEC 1695/1696 |
| SECFNY11 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 35 | SEC 1695/1696 |
| SECFNY12 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable Row 36 | SEC 1695/1696 |
| SECFNY13 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Payable - Unrated | SEC 1695/1696 |
| SECFNY14 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 1 | SEC 1695/1696 |
| SECFNY15 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 2 | SEC 1695/1696 |
| SECFNY16 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 3 | SEC 1695/1696 |
| SECFNY17 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 4 | SEC 1695/1696 |
| SECFNY18 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 5 | SEC 1695/1696 |
| SECFNY19 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 6 | SEC 1695/1696 |
| SECFNY20 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 7 | SEC 1695/1696 |
| SECFNY21 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 8 | SEC 1695/1696 |
| SECFNY22 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 9 | SEC 1695/1696 |
| SECFNY23 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 10 | SEC 1695/1696 |
| SECFNY24 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 11 | SEC 1695/1696 |
| SECFNY25 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 12 | SEC 1695/1696 |
| SECFNY26 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 13 | SEC 1695/1696 |
| SECFNY27 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 14 | SEC 1695/1696 |
| SECFNY28 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 15 | SEC 1695/1696 |
| SECFNY29 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 16 | SEC 1695/1696 |
| SECFNY30 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 17 | SEC 1695/1696 |
| SECFNY31 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 18 | SEC 1695/1696 |
| SECFNY32 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 19 | SEC 1695/1696 |
| SECFNY33 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 20 | SEC 1695/1696 |
| SECFNY34 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 21 | SEC 1695/1696 |
| SECFNY35 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 22 | SEC 1695/1696 |
| SECFNY36 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 23 | SEC 1695/1696 |
| SECFNY37 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 24 | SEC 1695/1696 |
| SECFNY38 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 25 | SEC 1695/1696 |
| SECFNY39 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 26 | SEC 1695/1696 |
| SECFNY40 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 27 | SEC 1695/1696 |
| SECFNY41 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 28 | SEC 1695/1696 |
| SECFNY42 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 29 | SEC 1695/1696 |
| SECFNY43 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 30 | SEC 1695/1696 |
| SECFNY44 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 31 | SEC 1695/1696 |
| SECFNY45 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 32 | SEC 1695/1696 |
| SECFNY46 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 33 | SEC 1695/1696 |
| SECFNY47 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 34 | SEC 1695/1696 |
| SECFNY48 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 35 | SEC 1695/1696 |
| SECFNY49 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value Row 36 | SEC 1695/1696 |
| SECFNY50 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Net Replacement Value - Unrated | SEC 1695/1696 |
| SECFNY51 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 1 | SEC 1695/1696 |
| SECFNY52 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 2 | SEC 1695/1696 |
| SECFNY53 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 3 | SEC 1695/1696 |
| SECFNY54 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 4 | SEC 1695/1696 |
| SECFNY55 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 5 | SEC 1695/1696 |
| SECFNY56 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 6 | SEC 1695/1696 |
| SECFNY57 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 7 | SEC 1695/1696 |
| SECFNY58 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 8 | SEC 1695/1696 |
| SECFNY59 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 9 | SEC 1695/1696 |
| SECFNY60 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 10 | SEC 1695/1696 |
| SECFNY61 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 11 | SEC 1695/1696 |
| SECFNY62 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 12 | SEC 1695/1696 |
| SECFNY63 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 13 | SEC 1695/1696 |
| SECFNY64 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 14 | SEC 1695/1696 |
| SECFNY65 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 15 | SEC 1695/1696 |
| SECFNY66 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 16 | SEC 1695/1696 |
| SECFNY67 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 17 | SEC 1695/1696 |
| SECFNY68 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 18 | SEC 1695/1696 |
| SECFNY69 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 19 | SEC 1695/1696 |
| SECFNY70 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 20 | SEC 1695/1696 |
| SECFNY71 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 21 | SEC 1695/1696 |
| SECFNY72 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 22 | SEC 1695/1696 |
| SECFNY73 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 23 | SEC 1695/1696 |
| SECFNY74 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 24 | SEC 1695/1696 |
| SECFNY75 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 25 | SEC 1695/1696 |
| SECFNY76 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 26 | SEC 1695/1696 |
| SECFNY77 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 27 | SEC 1695/1696 |
| SECFNY78 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 28 | SEC 1695/1696 |
| SECFNY79 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 29 | SEC 1695/1696 |
| SECFNY80 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 30 | SEC 1695/1696 |
| SECFNY81 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 31 | SEC 1695/1696 |
| SECFNY82 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 32 | SEC 1695/1696 |
| SECFNY83 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 33 | SEC 1695/1696 |
| SECFNY84 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 34 | SEC 1695/1696 |
| SECFNY85 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 35 | SEC 1695/1696 |
| SECFNY86 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable Row 36 | SEC 1695/1696 |
| SECFNY87 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net Exposure Current Payable - Unrated | SEC 1695/1696 |
| SECFNY88 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 1 | SEC 1695/1696 |
| SECFNY89 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 2 | SEC 1695/1696 |
| SECFNY90 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 3 | SEC 1695/1696 |
| SECFNY91 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 4 | SEC 1695/1696 |
| SECFNY92 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 5 | SEC 1695/1696 |
| SECFNY93 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 6 | SEC 1695/1696 |
| SECFNY94 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 7 | SEC 1695/1696 |
| SECFNY95 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 8 | SEC 1695/1696 |
| SECFNY96 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 9 | SEC 1695/1696 |
| SECFNY97 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 10 | SEC 1695/1696 |
| SECFNY98 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 11 | SEC 1695/1696 |
| SECFNY99 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 12 | SEC 1695/1696 |
| SECFNZ00 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 13 | SEC 1695/1696 |
| SECFNZ01 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 14 | SEC 1695/1696 |
| SECFNZ02 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 15 | SEC 1695/1696 |
| SECFNZ03 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 16 | SEC 1695/1696 |
| SECFNZ04 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 17 | SEC 1695/1696 |
| SECFNZ05 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 18 | SEC 1695/1696 |
| SECFNZ06 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 19 | SEC 1695/1696 |
| SECFNZ07 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 20 | SEC 1695/1696 |
| SECFNZ08 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 21 | SEC 1695/1696 |
| SECFNZ09 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 22 | SEC 1695/1696 |
| SECFNZ10 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 23 | SEC 1695/1696 |
| SECFNZ11 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 24 | SEC 1695/1696 |
| SECFNZ12 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 25 | SEC 1695/1696 |
| SECFNZ13 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 26 | SEC 1695/1696 |
| SECFNZ14 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 27 | SEC 1695/1696 |
| SECFNZ15 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 28 | SEC 1695/1696 |
| SECFNZ16 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 29 | SEC 1695/1696 |
| SECFNZ17 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 30 | SEC 1695/1696 |
| SECFNZ18 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 31 | SEC 1695/1696 |
| SECFNZ19 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 32 | SEC 1695/1696 |
| SECFNZ20 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 33 | SEC 1695/1696 |
| SECFNZ21 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 34 | SEC 1695/1696 |
| SECFNZ22 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 35 | SEC 1695/1696 |
| SECFNZ23 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure Row 36 | SEC 1695/1696 |
| SECFNZ24 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure - Unrated | SEC 1695/1696 |
| SECFNZ25 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value -Current Net and Potential Exposure - Totals | SEC 1695/1696 |
| SECFNZ26 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 1 | SEC 1695/1696 |
| SECFNZ27 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 2 | SEC 1695/1696 |
| SECFNZ28 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 3 | SEC 1695/1696 |
| SECFNZ29 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 4 | SEC 1695/1696 |
| SECFNZ30 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 5 | SEC 1695/1696 |
| SECFNZ31 | 2021-10-06 | 9999-12-31 | Schedule 3 Portfolio summary of derivatives expsoures by internal credit rating: Gross Replacement Value - Margin Collected Row 6 | SEC 1695/1696 |
| SECFPJ45 | 2021-10-31 | 9999-12-31 | Note A: Money suspense and balancing differences, (No. of Items) | SEC 1695/1696 |
| SECFPJ46 | 2021-10-31 | 9999-12-31 | Note A: Money suspense and balancing differences, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ47 | 2021-10-31 | 9999-12-31 | Note A: Money suspense and balancing differences, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ48 | 2021-10-31 | 9999-12-31 | Note A: Money suspense and balancing differences, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ49 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances L, (No. of Items) | SEC 1695/1696 |
| SECFPJ50 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances L, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ51 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances L, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ52 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances L, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ53 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances S, (No. of Items) | SEC 1695/1696 |
| SECFPJ54 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances S, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ55 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances S, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ56 | 2021-10-31 | 9999-12-31 | Note A: Security suspense and differences with related money balances S, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ57 | 2021-10-31 | 9999-12-31 | Note A: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (No. of Items) | SEC 1695/1696 |
| SECFPJ58 | 2021-10-31 | 9999-12-31 | Note A: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ59 | 2021-10-31 | 9999-12-31 | Note A: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ60 | 2021-10-31 | 9999-12-31 | Note A: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ61 | 2021-10-31 | 9999-12-31 | Note A: Market value of security record breaks, (No. of Items) | SEC 1695/1696 |
| SECFPJ62 | 2021-10-31 | 9999-12-31 | Note A: Market value of security record breaks, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ63 | 2021-10-31 | 9999-12-31 | Note A: Market value of security record breaks, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ64 | 2021-10-31 | 9999-12-31 | Note A: Market value of security record breaks, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ65 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (No. of Items) | SEC 1695/1696 |
| SECFPJ66 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ67 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ68 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ69 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (No. of Items) | SEC 1695/1696 |
| SECFPJ70 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ71 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ72 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ73 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: B. Depositories, (No. of Items) | SEC 1695/1696 |
| SECFPJ74 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: B. Depositories, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ75 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: B. Depositories, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ76 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: B. Depositories, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ77 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations L, (No. of Items) | SEC 1695/1696 |
| SECFPJ78 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations L, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ79 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations L, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ80 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations L, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ81 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations S, (No. of Items) | SEC 1695/1696 |
| SECFPJ82 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations S, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ83 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations S, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ84 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: C. Clearing organizations S, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ85 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: D. Inter-company accounts, (No. of Items) | SEC 1695/1696 |
| SECFPJ86 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: D. Inter-company accounts, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ87 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: D. Inter-company accounts, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ88 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: D. Inter-company accounts, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ89 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: E. Bank accounts and loans, (No. of Items) | SEC 1695/1696 |
| SECFPJ90 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: E. Bank accounts and loans, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ91 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: E. Bank accounts and loans, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ92 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: E. Bank accounts and loans, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ93 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: F. Other, (No. of Items) | SEC 1695/1696 |
| SECFPJ94 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: F. Other, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ95 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: F. Other, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPJ96 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: F. Other, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPJ97 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: G. (Offsetting) Lines 5A through 5F, (No. of Items) | SEC 1695/1696 |
| SECFPJ98 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: G. (Offsetting) Lines 5A through 5F, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPJ99 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: G. (Offsetting) Lines 5A through 5F, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK00 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (No. of Items) | SEC 1695/1696 |
| SECFPK01 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK02 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK03 | 2021-10-31 | 9999-12-31 | Note A: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK04 | 2021-10-31 | 9999-12-31 | Note A: Commodity differences, (No. of Items) | SEC 1695/1696 |
| SECFPK05 | 2021-10-31 | 9999-12-31 | Note A: Commodity differences, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK06 | 2021-10-31 | 9999-12-31 | Note A: Commodity differences, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK07 | 2021-10-31 | 9999-12-31 | Note A: Commodity differences, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK08 | 2021-10-31 | 9999-12-31 | Note A: Open transfers and reorganization account items over 40 days not confirmed or verified, (No. of Items) | SEC 1695/1696 |
| SECFPK09 | 2021-10-31 | 9999-12-31 | Note A: Open transfers and reorganization account items over 40 days not confirmed or verified, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK10 | 2021-10-31 | 9999-12-31 | Note A: Open transfers and reorganization account items over 40 days not confirmed or verified, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK11 | 2021-10-31 | 9999-12-31 | Note A: Open transfers and reorganization account items over 40 days not confirmed or verified, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK12 | 2021-10-31 | 9999-12-31 | Note A: TOTAL (Lines 1-7), (No. of Items) | SEC 1695/1696 |
| SECFPK13 | 2021-10-31 | 9999-12-31 | Note A: TOTAL (Lines 1-7), (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK14 | 2021-10-31 | 9999-12-31 | Note A: TOTAL (Lines 1-7), (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK15 | 2021-10-31 | 9999-12-31 | Note A: TOTAL (Lines 1-7), (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK16 | 2021-10-31 | 9999-12-31 | Note A: Lines 1-6 resolved subsequent to report date, (No. of Items) | SEC 1695/1696 |
| SECFPK17 | 2021-10-31 | 9999-12-31 | Note A: Lines 1-6 resolved subsequent to report date, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK18 | 2021-10-31 | 9999-12-31 | Note A: Lines 1-6 resolved subsequent to report date, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK19 | 2021-10-31 | 9999-12-31 | Note A: Lines 1-6 resolved subsequent to report date, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK20 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to deliver, (No. of Items) | SEC 1695/1696 |
| SECFPK21 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to deliver, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK22 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to deliver, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK23 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to deliver, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK24 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to receive, (No. of Items) | SEC 1695/1696 |
| SECFPK25 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to receive, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK26 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to receive, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK27 | 2021-10-31 | 9999-12-31 | Note A: Aged fails - to receive, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK28 | 2021-10-31 | 9999-12-31 | Note A: Have the accounts enumerated on Lines 5A through 5F above been reconciled with statements received from others within 35 days for Lines 5A through 5D and 65 days for Lines 5E and 5F prior to the report date and have all reconciling differences been appropriately comprehended in the computation of net capital at the report date? If this has not been done in all respects, answer No (Yes) | SEC 1695/1696 |
| SECFPK29 | 2021-10-31 | 9999-12-31 | Note A: Have the accounts enumerated on Lines 5A through 5F above been reconciled with statements received from others within 35 days for Lines 5A through 5D and 65 days for Lines 5E and 5F prior to the report date and have all reconciling differences been appropriately comprehended in the computation of net capital at the report date? If this has not been done in all respects, answer No (No) | SEC 1695/1696 |
| SECFPK30 | 2021-10-31 | 9999-12-31 | Note A: Do the respondent's books reflect a concentrated position in commodities? If yes, report the totals ($000 omitted) in accordance with the specific instructions. If No, answer "0", A. Firm trading and investment accounts | SEC 1695/1696 |
| SECFPK31 | 2021-10-31 | 9999-12-31 | Note A: Do the respondent's books reflect a concentrated position in commodities? If yes, report the totals ($000 omitted) in accordance with the specific instructions. If No, answer "0", B. Customers' and non-customers' and other accounts | SEC 1695/1696 |
| SECFPK32 | 2021-10-31 | 9999-12-31 | Note A: Does respondent have any planned operational changes? (Yes) | SEC 1695/1696 |
| SECFPK33 | 2021-10-31 | 9999-12-31 | Note A: Does respondent have any planned operational changes? (No) | SEC 1695/1696 |
| SECFPK34 | 2021-10-31 | 9999-12-31 | Note B: Money suspense and balancing differences, (No. of Items) | SEC 1695/1696 |
| SECFPK35 | 2021-10-31 | 9999-12-31 | Note B: Money suspense and balancing differences, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK36 | 2021-10-31 | 9999-12-31 | Note B: Money suspense and balancing differences, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK37 | 2021-10-31 | 9999-12-31 | Note B: Money suspense and balancing differences, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK38 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances L, (No. of Items) | SEC 1695/1696 |
| SECFPK39 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances L, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK40 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances L, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK41 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances L, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK42 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances S, (No. of Items) | SEC 1695/1696 |
| SECFPK43 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances S, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK44 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances S, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK45 | 2021-10-31 | 9999-12-31 | Note B: Security suspense and differences with related money balances S, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK46 | 2021-10-31 | 9999-12-31 | Note B: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (No. of Items) | SEC 1695/1696 |
| SECFPK47 | 2021-10-31 | 9999-12-31 | Note B: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK48 | 2021-10-31 | 9999-12-31 | Note B: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK49 | 2021-10-31 | 9999-12-31 | Note B: Market value of short and long security suspense and differences without related money balances (other than reported in Line 4, below), (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK50 | 2021-10-31 | 9999-12-31 | Note B: Market value of security record breaks, (No. of Items) | SEC 1695/1696 |
| SECFPK51 | 2021-10-31 | 9999-12-31 | Note B: Market value of security record breaks, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK52 | 2021-10-31 | 9999-12-31 | Note B: Market value of security record breaks, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK53 | 2021-10-31 | 9999-12-31 | Note B: Market value of security record breaks, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK54 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (No. of Items) | SEC 1695/1696 |
| SECFPK55 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK56 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK57 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS L, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK58 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (No. of Items) | SEC 1695/1696 |
| SECFPK59 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK60 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK61 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: A. Correspondents, broker-dealers, SBSDs, and MSBS S, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK62 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: B. Depositories, (No. of Items) | SEC 1695/1696 |
| SECFPK63 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: B. Depositories, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK64 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: B. Depositories, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK65 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: B. Depositories, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK66 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations L, (No. of Items) | SEC 1695/1696 |
| SECFPK67 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations L, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK68 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations L, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK69 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations L, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK70 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations S, (No. of Items) | SEC 1695/1696 |
| SECFPK71 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations S, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK72 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations S, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK73 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: C. Clearing organizations S, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK74 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: D. Inter-company accounts, (No. of Items) | SEC 1695/1696 |
| SECFPK75 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: D. Inter-company accounts, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK76 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: D. Inter-company accounts, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK77 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: D. Inter-company accounts, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK78 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: E. Bank accounts and loans, (No. of Items) | SEC 1695/1696 |
| SECFPK79 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: E. Bank accounts and loans, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK80 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: E. Bank accounts and loans, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK81 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: E. Bank accounts and loans, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK82 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: F. Other, (No. of Items) | SEC 1695/1696 |
| SECFPK83 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: F. Other, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK84 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: F. Other, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK85 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: F. Other, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK86 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: G. (Offsetting) Lines 5A through 5F, (No. of Items) | SEC 1695/1696 |
| SECFPK87 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: G. (Offsetting) Lines 5A through 5F, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK88 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: G. (Offsetting) Lines 5A through 5F, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK89 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (No. of Items) | SEC 1695/1696 |
| SECFPK90 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK91 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK92 | 2021-10-31 | 9999-12-31 | Note B: Unresolved reconciling differences with others: TOTAL (Lines 5A-5G), (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK93 | 2021-10-31 | 9999-12-31 | Note B: Commodity differences, (No. of Items) | SEC 1695/1696 |
| SECFPK94 | 2021-10-31 | 9999-12-31 | Note B: Commodity differences, (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK95 | 2021-10-31 | 9999-12-31 | Note B: Commodity differences, (Credits (Long Value)) | SEC 1695/1696 |
| SECFPK96 | 2021-10-31 | 9999-12-31 | Note B: Commodity differences, (Deductions in Computing Net Capital) | SEC 1695/1696 |
| SECFPK97 | 2021-10-31 | 9999-12-31 | Note B: TOTAL (Lines 1-6), (No. of Items) | SEC 1695/1696 |
| SECFPK98 | 2021-10-31 | 9999-12-31 | Note B: TOTAL (Lines 1-6), (Debits (Short Value)) | SEC 1695/1696 |
| SECFPK99 | 2021-10-31 | 9999-12-31 | Note B: TOTAL (Lines 1-6), (Credits (Long Value)) | SEC 1695/1696 |
| SECFPL00 | 2021-10-31 | 9999-12-31 | Note B: TOTAL (Lines 1-6), (Deductions in Computing Net Capital) | SEC 1695/1696 |